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ABSTRACT

Yoakum, Ryan J. Ph.D., Biomedical Sciences Program, Wright State University,
2015. Modification Reactivity Analysis of human Replication Protein A in Biologically
Important States

Human Replication Protein A (RPA) is a heterotrimeric protein consisting of 70,
32, and 14 kDa subunits. RPA is the predominant single stranded DNA binding protein
within the cell. It is involved in all forms of the DNA metabolic pathways, including but
not limited to, replication, recombination, damage repair, as well as cell cycle and DNA
check point signaling. RPA is phosphorylated (pRPA) during G1-S phase and is
dephosphorylated during M phase. Further, RPA is hyperphosphorylated during DNA
damage.
Through the use of x-ray crystallography and nuclear magnetic resonance,
researchers have proposed models and structures based on truncated portions of the
protein. Currently, there are no x-ray crystallographic or NMR models for the full RPA
heterotrimer. Our lab, using chemical modification reactivity analysis data (MRAN) and
simulated annealing, has a proposed model for the complete structure of native RPA
unbound to ssDNA.
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To further refine models for the complete structure of RPA, we have used a
series of experiments in which the structure of RPA was probed via Chemical
Modification Reactivity Analysis (MRAN). Specifically, lysines within RPA were probed by
sulfo-NHS-acetate and aspartates and glutamates were probed with N-(3dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) chemical reagents
under conditions in which RPA was in native, phoshphorylated, single strand DNA
(ssDNA) bound, and phosphorylated ssDNA bound states to determine the structural
changes that result from different binding and phosphorylation states. Chemical
modification and exhaustive proteolysis were used in conjunction with MALDI-TOF mass
spectrometry to determine local and global structural changes that occur within the
protein under each specific reaction condition.
Through the use of photochemical crosslinks between RPA and dT30 ssDNA, the
sites and specific amino acids involved in binding between RPA and ssDNA were
mapped. All DNA binding domains (DBDs) of the heterotrimer were shown to interact
with the ssDNA including the 14 kDa subunit (DBD E). The interaction between DBDs A,
B, C, D, and F coincided with reports of the interaction between RPA and ssDNA. Our
data for the interaction between DBD E of the 14 kDa subunit and ssDNA provides a
strong argument that the 14kDa subunit is involved in at least one mechanism of ssDNA
binding within the cell. MRAN data further suggests that the modular rearrangement of
RPA is necessary, and that RPA goes from a compact conformation with DBDs A & B
v

docked to the trimerization core in the ligand-free state to an extended conformation in
which DBDs A & B are extended by a tethered region away from the trimerization core
of RPA when bound to ssDNA.
Further, the structural analysis of RPA and pRPA through chemical modification
reactivity analyses in both apo and ssDNA bound states provides greater detail of the
local conformational changes that the heterotrimer undergoes between these states.
This data suggests that RPA and pRPA are similar and that the molecule undergoes
specific local changes due to changes in electrostatic and hydrophobic potential of
specific amino acids within each domain. It further demonstrates that the local changes
in surface accessibility do not affect global structure of the domains, or of the molecule
as a whole, but rather represents minor changes that influence specific amino acidligand interactions. The data suggest that RPA and pRPA undergo a significant
rearrangement when bound to ssDNA. The dissociation of DBDs A & B from the
trimerization core represents a significant change in structure from the ssDNA free
state. Evaluation of these changes in relation to proposed structures for RPA allows for
targeted adjustments to the proposed models to better fit experimental data and gives
a more accurate representation of the structure in solution under each reaction
condition.
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1. OVERVIEW OF HUMAN REPLICATION PROTEIN A and MODIFICATION
REACTIVITY ANALYSIS
Replication protein A (RPA) is a single stranded DNA binding protein (SSB) and
was originally purified from human cell extracts as a component essential for simian
virus 40 (SV40) DNA replication in vitro1. RPA binds with high affinity to single strand
DNA (ssDNA) and with much lower affinity to double strand DNA (dsDNA) and RNA2.
Although several eukaryotic SSB’s have been identified previously from both viruses and
cells, RPA was the first cellular SSB that was shown to be directly involved in DNA
metabolism3. RPA is in high abundance in human cells and appears to be the most
abundant SSB4. There are estimated to be between 3x10 4–5 and 2 x 105 molecules of
RPA per cell in transformed human cells5.
RPA is a hetero-trimeric protein consisting of 70, 32, and 14 kDa subunits5
(Figure 1). It is involved in, but not limited to: replication, recombination, damage repair,
as well as cell cycle and DNA check point signaling6. RPA has multiple binding partners,
and serves the role of a recognition factor6. Crystal structures for individual subunits or
truncated and modified segments of RPA have been reported7, but as yet, no
crystallographic or NMR-based three-dimensional structural image of the complete
holoenzyme or the apoenzyme8 has been reported. Using a variety of experimental
methods, 6 oligonucleotide/oligosaccharide binding regions (OB) or DNA Binding
Domain (DBD) structures have been proposed for RPA. The DBDs are labeled A-F, and
1

Figure 1. Schematic representation of the 3 subunits of RPA.

2

3

consist of 5  strands in a Greek-key  barrel9. The 70 kDa subunit contains DNA binding
domains F, A, B, and C (Figure 1) as well as non-structured regions within the N terminus
(Figure 2)10. The 32 kDa subunit contains DBD D and the 14 kDa subunit contains DBD E
(Figure 1)10. Not all DBDs have been assigned a DNA binding function.
No disorders are associated with the genes that code for the subunits of RPA,
however, mutations and or deletions in genes and gene products known to interact with
RPA have been associated with breast, colon, and lymphoid cancers11,12,13. In mouse
models homozygotic deletion of RPA leads to embryonic lethality where as
heterozygotic deletion leads to tumorogenesis14.
Traditionally, to resolve protein structure, scientists have turned to x-ray
crystallography and nuclear magnetic resonance spectroscopy15 (NMR). While both xray crystallography and NMR are standards for resolving structural detail of proteins,
neither experimental approach is appropriate in understanding protein structure under
all physiological conditions. The dehydrated and closely packed crystal environment is
frequently high in salinity. This not only changes hydrophobic interaction, but also
changes electrostatic potential from physiological solution, and thus potentially changes
protein folding and amino acid interaction relative to the solution state. Further,
proteins are flexible, and contain highly disordered regions that may be resistant to
crystallization. This can make x-ray crystallization a poor choice for some proteins16,17,18.
NMR spectroscopy is limited by the size of the protein being studied. Many proteins fall
4

Figure 2. Ribbon model of M80PS Human Replication Protein A with subunits colored as
follows. The N terminus of the 70 kDa subunit (DBD F) painted brown, DBD A painted
raspberry, DBD B painted ruby, and DBD C painted salmon. The N terminus 32 kDa
subunit painted cyan, DBD D painted sky blue, and the C terminus painted blue. The 14
kDa subunit painted yellow. Unstructured regions were painted white.

5
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outside of the size range readily approachable by NMR, making this technique
impractical for some proteins as well17,19 ,20.
Another approach for resolving protein structure is computer modeling. While
current computational methods can provide rapid protein structure prediction, they can
be highly inaccurate21. When comparing modern predictive software with known crystal
structures, current software is able to accurately predict the structure of proteins less
than 50% of the time20. To resolve the limitations of x-ray crystallography, NMR
spectroscopy, and computer modeling, modification chemical reactivity analysis (MRAN)
was developed.
MRAN works on the principle that a protein’s three-dimensional structure is
reflected in an interpretable way by the reactivity of amino acids within that protein.
Targeted amino acids are analyzed by specific chemical probes to assess their chemical
reactivity based on selected physical characteristics of the microenvironment of those
residues8. These reactions reflect surface accessibility, electrostatic interactions, nearest
neighbor constraints as well as the chemical nature of the targeted residues22.
Determining which amino acids are affected by chemical modifiers describes shifts in
protein structure under varying conditions23. In essence, reactivity can indicate
conformation, and additionally, conformation can change.
Despite the complexity of protein structure, only a small number of protein
functional groups comprise selectable targets for practical modification methods 22. In
7

fact, just four protein functional groups are chemical targets for the vast majority of
crosslinking and chemical modification approaches. These functional groups consist of
primary amines, carboxyls, sulfhydryls, and carbonyls22. In principle, amino acids that
are surface-exposed are reactive with appropriate chemicals in solution23,24. Those that
are partially buried are fractionally reactive 24. Buried residues that have no solvent
accessibility are nonreactive. Tertiary structure of the protein dictates the reactivity of
its residues, and thus chemical reactions with amino acid functional groups reveals
structural information about the protein. Mass spectra obtained from samples treated
with covalent chemical modifiers, like acetylation and carboxy-methylation that target
amino acid functional groups, provide information on the environment of residues
within a protein, but there is still a significant gap in the field of protein modeling and its
real world application25.
Another approach that attempts to discern protein structure is predictive
modeling. Predictive modeling by computational methods produces a large selection of
structures that fit the criteria interposed by the software. Selecting which structure best
represents the protein in solution is aided by experimental data, like that provided by
MRAN. This approach provides new and greater detail in understanding the protein’s
structure and additionally allows probing of the structure in the presence of differing
conditions such as in the presence of ligand or substrate. Adapting MRAN data to
predictive modeling gives direct experimental observations that can be used to correlate
8

data from in vitro experiments with a predicted or reported structure, and
simultaneously rules out structures that conflict with observed reactivity data. Using this
analysis for a particular protein not only provides an insightful approach to tackling the
problem of determining a protein’s structure, but enhances the software,
crystallographic, and NMR based approaches to predictive modeling. These methods
were employed in studies reported here.
As RPA is a large and highly flexible protein that binds to ssDNA, it presents
unique challenges when assessing its structure in the presence or absence of ssDNA
ligand. To address this issue, photo-chemical covalent crosslinking is employed. Many
protein–nucleic acid complexes have been studied by photochemical crosslinking26. UVinduced crosslinking of protein to nucleic acids allows the structural analysis of the
conjugated protein to be to a specific amino acid residue in a portion of the nucleic acid
binding site. Additionally, covalent crosslinks between the protein and ssDNA assures
that the crosslinked protein retains the ssDNA, and any conformation unique to it when
probed by additional means. Mass spectrometry can be used to identify purified
peptide–nucleic acid heteroconjugates and place the amino acid in the protein’s primary
structure. The use of UV irradiation to photo crosslink ssDNA to RPA was deployed in
studies reported here to determine specific regions of the protein that are bound to the
DNA under a variety of experimental conditions27. This allowed direct determination of
the sites of interaction between RPA and single strand DNA. The UV-B induced
9

photocrosslinking reaction created a covalent bond between thymidines in a 5’6FAM
Poly T 30mer with lysines, tyrosines, and tryptophans in the protein (Figure 3).
Covalently crosslinking the ssDNA ligand to RPA, and its subsequent mass spectral
analysis provided direct evidence for all ssDNA interacting domains of the protein. More
specifically, the regions of each subunit of RPA that directly bind with ssDNA in native
and phosphorylated states were determined.
Matrix assisted laser deabsorbtion/ionization time of flight mass spectroscopy
(MALDI-TOF) is a frequently used technique for characterizing peptide fragments
generated during in vitro analysis of proteins28. It provides a very sensitive method for
identifying specific peptides in complex sample sets. Monitoring changes in the mass of
peptides by mass spectroscopy analysis allows all peptides generated through the
experimental protocols to be examined and specific locations of modifications to be
efficiently identified. One key element of this analysis is the identification of specific
peptides and amino acids that are modified by the chemical probing agents,
phosphorylated amino acids, as well as covalently crosslinked segments of protein with
ssDNA.

10

Figure 3. Adducts arising from the photoreactions of thymine with cysteine (left), Nacetyltyrosine (right) and the reaction of thymidine with lysine (bottom).

11
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RPA Domain and Subunit Structural Information
RPA 70
Binding interactions involving the 70 kDa subunit have been implicated in many
critical activities within the cell. The 70 Kda subunit contains DBDs A & B, which
combined, make the highest affinity reactive sites for ssDNA binding within the protein.
This subunit is essential for DNA replication, repair, and recombination29. The N
terminus of the 70 kDa subunit interacts with a multitude of proteins partners.
Interactions between SV40T antigen30, GAL431, VP1632, and p5333 have been mapped to
both the N-terminal domain (residues 1-110) and to the A & B DBDs (residues 170-450).
The N-terminus of the 70 kDa subunit is the region of the 70 kDa subunit associated
with the stimulation of DNA polymerase alpha/primase34. The 70 kDa subunit also binds
with DNA helicases and stimulates the unwinding of hundreds to thousands of
nucleotides35. Proximal to the 70 N-terminal region and connected by a linker region are
DNA binding domains, A & B36. DBD A has the highest affinity for ssDNA2. DBD B is
connected to DBD A by a short linker region and together with DBD A, is associated with
the small DNA substrate binding mode of RPA37. DBDs A & B can bind to a 8 nt single
strand ligand, the minimum length ligand necessary for DNA binding38 with the entire
protein. Deletion mutants of RPA which lack the A and B domain are replication
deficient and cause cell death39. On the C terminus of the 70 kDa subunit and connected
to DBD B again by an unstructured linker region is another DNA binding domain, DBD
13

C40. DBD C has lower affinity for ssDNA than A or B, and also is thought to serve a
structural role for formation of the hetero-trimeric RPA complex40 by interacting with
the 14 and 32 kDa subunits. The C-terminal domain contains a putative zinc-finger motif
near residue 500. This zinc-finger is conserved in all RPA homologues41.
RPA 32
As with the 70 kDa subunit, the 32 kDa subunit is essential for RPA function42.
The N terminus of the 32 kDa subunit is phosphorylated in a cell cycle dependent
manner, with deletion analysis showing that the N-terminal 35 amino acids are essential
for phosphorylation6. The phosphorylated amino acids in the N terminus of the 32 kDa
subunit are proposed to be in an exposed/extended conformation that changes after
RPA binds to single strand DNA43. Deletion of the N-terminus of the 32 kDa subunit does
not affect ssDNA binding affinity, RPA complex formation, or the ability of RPA to
stimulate DNA polymerase activity and support DNA replication in vitro6. The Nterminus of the 32 kDa subunit has also been shown to be involved in protein-protein
interactions43. More specifically, XPA, RAD51, and uracil-DNA glycosylase have direct
interaction with the N-terminus of the 32 kDa subunit44,45. The 32 kDa subunit also
contains DBD D, a low affinity DNA binding site, and a winged helix motif at its C
terminus10.
RPA 14
The 14 kDa subunit is essential for RPA function. While the 14 kDa subunit has an
14

OB fold, DBD E, it is believed that this subunit serves a structural role necessary for
proper formation of the heterotrimer10. EMSA analysis has shown that the 14 kDa
subunit binds to ssDNA. However, no structural models presented to date support this
evidence46.
Phosphorylation
An important aspect of RPA’s structure and function is its phosphorylation state.
Researchers report a large number of potential phosphorylation sites in RPA 47, 48.
Phosphorylation of RPA occurs in a cell cycle dependent manner and in response to DNA
damage49. This phosphorylation of RPA occurs at multiple serine and threonine
residues50. The N terminus of RPA’s 32 kDa subunit is essential for its phosphorylation51
and requires that ssDNA be bound to RPA52. The stimulation of phosphorylation in the
presence of ssDNA is thought to be caused by a DNA induced change in conformation of
the 32 kDa subunit, which presents a more favorable surface for phosphorylation49. RPA
is phosphorylated during G1-S phase and is dephosphorylated during M phase50.
Replication Protein A is hyperphosphorylated during DNA damage48. RPA is
phosphorylated by multiple kinases, including the cyclin-dependent kinase family (Cdk,
also known as the p34cdc2 kinase family)50, the DNA-dependent protein kinase (DNAPK)50, and the ATM-ATR family of kinases53, as well as several uncharacterized kinases.
DNA-unwinding activity in the presence of RPA is stimulated after phosphorylation by
p34cdc2 kinase54. While Cdk family kinases activate G1 extracts for replication and RPA
15

phosphorylation, they are responsible for little if any direct phosphorylation of RPA55.
Primarily, phosphorylation of RPA is through DNA-dependent protein kinase (DNA-PK)49.
DNA-PK is a serine/threonine kinase that is activated by dsDNA56. DNA-PK is involved in
both recombination and DNA repair56. Cells with decreased DNA-PK activity have
defects in RPA phosphorylation33. Phosphorylation of RPA inhibits its interaction with
replication centers. The phosphorylation of RPA directly affects its structure and more
specifically its function within the cell47. Understanding changes to the structure of RPA
caused by its phosphorylation state provides greater insight into the rearrangement of
the protein as it performs different functions within the cell.
ssDNA Binding
RPA binds tightly to ssDNA as a heterotrimeric complex57 with an apparent
association constant of 1x109–1011 M−1, 2,58, . The affinity of RPA for both dsDNA and RNA
is at least three orders of magnitude lower than it is for ssDNA2 with the hierarchy of
RPA binding to nucleic acids in order of decreasing affinity as follows: ss-polypyrimidines
> ssDNA with mixed sequence > ss-polypurines > RNA > dsDNA39. RPA shows a distinct
preference for binding polypyrimidine sequences over polypurine sequences with a 50fold higher preference for pyrimidines31. Analysis of binding to oligonucleotides of
varying length showed that RPA has a strong length dependence for binding1. The
affinity of RPA for oligodeoxythymidine of 30 residues in length (dT30) was high (Kd
1x109 M−1)59, but as length decreases the affinity constant decreases by almost two
16

orders of magnitude (dT15, Kd 1x109 M−1; dT12, Kd 2 x 108 M−1; and dT10, Kd 7 x 107
M−1)59. The length of the occluded binding site for RPA has been defined as 30
nucleotides (nt) in length and the cooperativity of RPA binding has been shown to be
very low30. However, RPA is still 10–20 times more likely to bind adjacent to an already
bound molecule of RPA3. RPA undergoes a conformational change when it binds to
ssDNA60. This change has been demonstrated by microscopic visualization of RPA
complexes and by changes in proteolytic sensitivity60. This conformational change
involves both the 70 kDa subunit and the 32 kDa subunit61. When accounting for the
contour length of ssDNA coated with RPA, it appears that DNA does not wrap around
RPA. More so, deletion analysis has identified the central region of the 70 kDa subunit of
RPA, (residues 170-450) DBDs A & B, as the region necessary for high-affinity ssDNAbinding31.
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Hypothesis and Specific Aims
Hypothesis:
RPA undergoes a structural rearrangement when phosphorylated. Additionally, RPA
undergoes structural changes when bound to ssDNA. The structure undergoes further
changes between the phosphorylated and phosphorylate ssDNA bound states.
Specific Aims:
1) Determine all interaction sites associated with ssDNA binding in native and
phosphorylated RPA.
2) Identify structural changes associated with DNA binding and phosphorylation of
Human Replication Protein A.
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2. Rationale
Introduction
RPA Purification
Using an expression system, Escherichia coli with recombinant RPA, we were
able to express and purify milligram quantities of RPA. The standard protocol used
Cibacron Blue affinity chromatography in conjunction with hydroxylapatite and Q
sepharose columns5 (Figure 4). It is with the highly purified protein product that all
subsequent assays were conducted.
RPA adducts
Understanding any structural changes that occur within RPA when in it is in its
phosphorylated state was one of the primary goals of our research. To achieve this, in
vitro hyperphosphorylated RPA was produced and purified by incubating purified RPA
extracted from Escherichia coli with HeLa cell extracts to induce the DNA damage
phosphorylation pathways48. Further, identifying sites of ssDNA binding as well as
structural differences between RPA and pRPA were also of interest. To produce and
purify RPA or pRPA ssDNA heteroconjugates, these proteins were preincubated with a
single strand poly dT30mer containing a 5’ 6FAM fluorophore (Figure 6), and subjected
to UV-B light to achieve photo crosslinking (Figure 3).
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Figure 4. Purification Scheme of the p11d-tRPA Plasmid for the Purification of Human
Replication Protein A.
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RPA and pRPA chemical modifications
Structural characteristics of 4 different reactive states of RPA, pRPA, ssDNA:RPA,
and ssDNA:pRPA were investigated by modification reactivity analyses. RPA, pRPA,
ssDNA:RPA, and ssDNA:pRPA were incubated with either sulfo-NHS-acetate, or EDC and
glycine methyl ester (Figure 5). The sulfo-NHS-acetate reaction targeted lysines within
the protein and produced an acetylated lysine adduct for all surface exposed lysines
involved in the reaction. EDC and glycine methyl ester targeted the carboxylic acids,
aspartate and glutamate, forming an acyl glycine ester on all surface exposed carboxylic
acids in the protein62.
SDS PAGE and In-Gel Exhaustive Digestion
SDS PAGE was used to visualize purified fractions of RPA, separate reacted
protein products from reaction mixtures, report phosphorylation of RPA, as well as
verify photo crosslinking of ssDNA with RPA. To ensure that preparations contained full
length RPA, pRPA, ssDNA:RPA and ssDNA:pRPA, bands assigned to the 70, 32, and 14
kDa subunits for RPA and pRPA as well as, bands assigned to ssDNA:RPA and
ssDNA:pRPA covalent heterconjugates were excised from the gel and subjected to
exhaustive in-gel digestion. This provided homogenous samples for each subunit or
heteroconjugate and eliminated the potential of introducing truncated species in
samples submitted for mass spectral analysis. Covalently crosslinked protein:dna
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Figure 5. Reagents used to covalently label Replication Protein A. The top panel shows
the acetylating reagent N-hydroxysulfosuccinimidyl acetate (sulfo-nhs acetate). The
bottom panel shows N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride
(ECD).
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heteroconjugates were found to be resistant to proteolysis, therefore, Micrococcal
nuclease was first used to exhaustively digest the crosslinked ssDNA substrate bound to
RPA63. For each reaction condition, samples were digested with trypsin for 1 set of mass
spectral analyses. Separate gels were digested with chymotrypsin using the same
experimental conditions for a second set of mass spectral analyses. The experimental
scheme utilized the differing weights and physical properties resulting from the
separate proteolytic digestions to improve total sequence coverage for the protein and
subunits investigated by mass spectral analysis. Through this scheme we were able to
improve sequence coverage to 80% for all 3 subunits of RPA. Sequence coverage of
amino acids in the interaction sites of each subunit was 97.7%, 86.0%, 88.4%, and 82.6%
for RPA, ssDNA:RPA, pRPA, ssDNA:pRPA, respectively (data not shown).
Mass Spectrometry of RPA, pRPA, ssDNA:RPA and ssDNA:pRPA
Monitoring changes in the mass of peptides by mass spectroscopic analysis
provides a very sensitive method for identifying specific peptides in complex sample sets
and allows all peptides generated through the experimental protocols reported here to
be examined. Specific locations of peptides and amino acids that are phosphorylated,
modified by the chemical probing agents, as well as covalently crosslinked with ssDNA
can be efficiently identified. MMass mass spectrometry software (MMass.org) was used
to compare recorded spectra to predicted theoretical spectra of the covalently modified
proteins. Peaks were assessed for fit to predicted spectra to determine the presence of
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peaks assigned as products of the 70, 32, and 14 kDa subunits of RPA.
Materials and Methods
Chemicals
HEPES, Myo-Inositol, DTT, EDTA, NaSCN, KCL, KPO4, ZnCl, and Sulfo NHS Acetate,
Glycine methyl ester, and N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide
hydrochloride (ECD) were purchased from Sigma (St. Louis, MO). Hydroxylapatite was
purchased from TOSOH Bioscience (Grove City, OH). Protein grade IPTG and sequence
grade Trypsin and Chymotrypsin were purchased from Gold Biotechnology (St. Louis,
MO). Protease-phosphatase mini tablets and a protease inhibitor cocktail containing
Leupeptin, PMSF and Pepstatin A, as well as the Pageruler plus protein ladder were
purchased from Pierce (Rockford, IL). Bio-Rad protein assay kits were purchased from
Bio-Rad (Hercules, CA). A peptide standard for mass spectral calibration was purchased
from Bruker Daltonics (Billrica, MA). Mass Spectral Grade CHCA was purchased from
Fisher Scientific (Waltham, MA). Pro Q Diamond gel stains were purchased from Life
Technologies (Carlsbad, CA). Micrococcal nuclease was purchased from Worthington
Biochemical (Lakewood, NJ). A 5’6FAM dt30 was purchased from IDT (Coralville, IA)
(Figure 6).
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Figure 6. Structure of Fluoroscein attached to the 5’ end of the poly dT 30mer.
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Buffers
HI Buffer (30 mM HEPES p.H. 7.8, 0.25 % myo-inositol, 1 mM DTT, 0.25 mM EDTA, and
30 mM ZnCl) was used in experiments that were conducted on native RPA. For
purification experiments, HI buffer was modified as needed for each individual step.
Chromatographic columns were preloaded with HI buffer containing 1μM Leupeptin, 1
mM Pepstatin A, and 10 mM PMSF. Solutions containing, 80 mM KCl, 0.8 M KCl, 0.5 M
NaSCN, and 1.5 M NaSCN, were used for wash and elution steps involving a Cibacron
Blue column. Solutions containing 30 mM KCl, 80 mM KPO4, and 0.5 M KPO4 were used
for wash and elution involving the hydroxylapatite column, and solutions containing 50
mM KCL, 100 mM KCl, 200, mM KCl, and 400 mM KCl were used for wash and elution
steps involving the mono Q anion exchange column.
RPA Purification
Plasmid p11d-tRPA (Figure 7) which, contains DNA corresponding to all RPA subunits,
was obtained as a generous gift from Dr. Marc Wold (Department of Biochemistry,
University of Iowa College of Medicine). It is used to transform cells of the chemically
competent BL21 (DE3) strain of Escherichia coli. To accomplish this, 10 μl of plasmid
DNA solvated in Milipore H2O was mixed with 50 μl of chemically competent BL 21 cells,
and heated in a water bath to 42o C for 1 min. The DNA and competent cells were then
placed on ice for 5 min. The cells were then used to inoculate 80 ml of autoclaved LB
media and incubated at 37o C for 1 hr with shaking. 50 ml of cells were used to inoculate
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Figure 7. Plasmid p11d-tRPA used for the purification of Human Replication Protein A.
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Chloramphenicol and Ampicilin treated plates that were grown overnight at 37o C. A
single colony was used to inoculate 1L of autoclaved LB Media and allowed to incubate
overnight at 37o C without shaking. The inoculated media was then combined with
another liter of autoclaved LB media and placed into a Microferm fermentor (New
Brunswick Inc., Edison, NJ) reaction vessel with air settings of 3L/min (air at 70o C and
14.7 PSIA) and continual agitation. Cell growth was monitored by UV/Vis
spectrophotometry at 600 nM. When cells were in log phase growth (600 nM measuring
0.60) the transformed cells were then induced with 1 mM IPTG to express human
recombinant RPA. Cells were collected after 3hrs of induction, centrifuged at 4,000 rpm
in a Beckman Coulter (Beckman Coulter Inc., Hebron, KY) centrifuge with a JA-10 rotor
and pellets were collected. Cell pellets were solvated in 25 ml of HI buffer containing
protease inhibitors and lysed at 14,000 psi using an Emusliflex (Avestin Inc., Ottawa,
Canada). Cell lysate was centrifuged at 14,000 rpm in a JA-14 rotor in a Beckman Coulter
centrifuge (Beckman Coulter Inc., Hebron, KY) and collected. The purification is a slight
modification of a previously described procedure5 (Figure 4). To ensure zinc was
maintained in the protein, it was placed in higher concentration than EDTA for all
buffers5. Samples collected from the final chromatographic step of the purification were
electrophoresed on 12% SDS acrylamide gels and stained with coomassie blue to verify
purity (Figure 8).
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Figure 8. SDS Polyacrylamide gel stained with coomassie blue showing the final purified
product of Human Replication Protein A. Lane 1 is the MW ladder, lane 2 is a fraction of
purified hRPA, lane 3 is a fraction of purified hRPA, and lane 4 is a fraction of purified
hRPA.
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Phosphorylation of RPA
In vitro hyperphosphorylated RPA was prepared by incubating purified RPA extracted
from Escherichia coli with HeLa cell extracts supplemented with a Pierce protease
inhibitor cocktail containing sodium fluoride, sodium orthovanadate, sodium
pyrophosphate and beta-glycerophosphate. Prior to extraction, the HeLa cells were
treated with aphidoclin and hydroxyl-urea, to promote DNA damage and induce the
DNA damage phosphorylation pathways48. The kinases within the HeLa cell extracts
were used to phosphorylate RPA, and the resulting phosphorylated RPA was re-purified
using the same procedure as used to purify RPA5. Samples collected from the final
chromatographic step of the repurification were electrophoresed on 12% SDS
acrylamide gels and stained with coomassie blue to verify purity (Figure 9).

35

Figure 9. SDS polyacrylamide gel stained with coomassie blue showing the final purified
product of phosphorylated human Replication Protein A. Lane 1 is the MW ladder. Lane
2 is the final purified fraction of pRPA.

36

70

32

14

1

2

37

UV Crosslinking
To achieve covalent crosslinking, purified RPA or pRPA heterotrimers were preincubated
with a single strand poly dT30mer containing a 5’ 6FAM fluorophore using a Stratalinker
UV crosslinker (Stratagene California, La Jolla, CA). A stoichiometric ratio of 1μg RPA:
1μg DNA was placed into solution. 40 μl of RPA in HI buffer was mixed with 40 μl 5’ 6
FAM dT30mer in a 96 well flat bottom plate. The samples were then exposed to UV-B at
254 nm for the duration necessary to deliver a dose of 5000 μJoules. This dose was
determined by systematically increasing crosslinking UV dose and selecting the optimal
dose for crosslinking (Figure 10).
RPA and pRPA chemical modifications
Sulfo-NHS-acetate modification:
200 μl RPA, pRPA, RPA:ssDNA, or pRPA:ssDNA, were incubated with 300 μl 10 mM sulfoNHS-acetate stock solution for 80 min. The reaction was quenched by the addition 15 μl
of 10 mM Glycine for each 10 μl of sample. Sulfo-NHS-acetate covalently modifies lysine
residues in the protein (Figure 5)64.
EDC glycine methyl ester modification:
4 mM EDC and 5 mM glycine methyl ester was added to 1 mg/ml RPA, pRPA,
ssDNA:RPA, or ssDNA:pRPA, and incubated at room temp for 80 min. Reactions were
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Figure 10. Dose dependence of the UV-B photo crosslinking of 5’6FAM poly T ssDNA
30mer. Lane 1 is RPA with 0 exposure to UV-B. Lane 2 is RPA:ssDNA with 1,000 μJ UV.
Lane 3 is RPA:ssDNA with 2,000 μJ UV. Lane 4 is RPA:ssDNA with 3,000 μJ UV. Lane 5 is
RPA:ssDNA with 4,000 μJ UV. Lane 6 is RPA:ssDNA with 5,000 μJ UV.
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quenched by the addition of 0.014 μl beta mercaptoethanol. The EDC glycine methyl
ester reaction was used to covalently modify aspartate and glutamates within RPA and
pRPA (Figure 5)62.
Concentration with Bio-Rad protein Assay
To determine the concentration of the purified fractions collected from each
chromatographic elution step, for purified RPA, 10 μl aliquots were taken from each
fraction and combined via standard protocols with Bio-Rad protein assay solution in a 96
well plate. A Magellan uv/vis spectrophotmeter was used to scan the samples at a 595
nm wavelength. The results were then compared to a BSA standard curve to determine
overall protein concentration65 (Figure 11).
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Figure 11. A Plot showing the concentration of Human Replication Protein A compared
to a BSA standard curve after the final chromatographic step of purification.
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Fluorescence anisotropy
To determine RPA and pRPA dT30 binding activity, a Magellan UV/VIS
spectrophotometer was used to measure fluorescence anistropy (Figure 12). The
activity of RPA was determined by monitoring the binding of a poly dT30mer with an
attached 5’ 6FAM fluorophore to RPA. Increasing concentrations of 5’ 6FAM dT30mer
were added to a fixed concentration of RPA. Specific anistropy of the fluorescent ssDNA
oligomer was used to monitor oligonucleotide binding with each addition. As a control,
BSA was loaded with the same substrates, and differences in anisotropy were
evaluated65. Plotting the binding as a function of ssDNA concentration revealed a
stoichiometric relationship (1:1) for binding to RPA and pRPAs’ association with the
oligonucleotide with dissociation constants of approximately 1.7x10-9M and 2.0x10-10M
for RPA and pRPA respectively, which was consistent with a single binding site (Figures
13 & 14).
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SDS-PAGE SDS-polyacrylamide gel electrophoresis was used to analyze fractions from
the final step in the RPA purification (Figure 8). 10 μl of the purified hPRA
chromatographic fraction were mixed with 15 ul SDS loading buffer, boiled for 10 min at
90o C and loaded onto a 12% SDS-Polyacrylamide gel. Pageruler plus protein ladder was
used as a molecular weight standard. All gels were electrophoresed at a 60 mA constant
current using the Bio-Rad mini gel system. Gels were stained with coomassie blue and
destained with standard wash and destain solutions. Gels were then imaged in a Bio-Rad
Gel imager for final visualization.
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Figure 12. RPA fluorescence anisotropy. Representative plot of a fixed concentration of
human Replication Protein with an increasing concentrations of ssDNA.
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Figure 13. Concentration dependence of ssDNA binding to RPA. Kd 1.7x10 -9. Binding
data from multiple runs were fit to a single site association model using a nonlinear
regression analysis implemented on Slide Write.
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Figure 14. Concentration dependence of ssDNA Binding to pRPA. Kd 2.0x10-10. Binding
data from multiple runs were fit to a single site association model using a nonlinear
regression analysis implemented on Slide Write.
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Phosphate Imaging
To verify the phosphorylation of RPA, putatively phosphorylated samples were collected
and 10 μl aliquots were mixed with 15 μl of SDS loading buffer, boiled at 90o C for 10
min, and then loaded onto a 15% SDS-polyacrylamide gel and electrophoresed at 60 mA.
After electrophoresis the gel was stained with Pro-Q Diamond gel dye, a dye that
specifically binds to phosphorylated peptides. The gel was then imaged in a Bio-Rad gel
imager with specific filters for Pro-Q diamond to visualize bands containing the
phosphorylated RPA (Figure 15). The gel was then destained and restained with Sypro
Ruby protein stain and imaged on the Bio-Rad gel imager with filters for Sypro Ruby
(data not shown). This allowed us to compare the total protein within the gel with
phosphorylated protein, as well as to identify subunits of RPA which were
phoshphorylated.
Figure 15. SDS polyacrylamide gel of pRPA stained with Pro Q diamond. Lane 1 is the
Pageruler plus protein ladder. Lane 2 is blank. Lane 3 is native RPA. Lane 4 is fraction 1
of pRPA. Lane 5 is fraction 2 of pRPA. Lane 6 is fraction 3 of pRPA. Lane 7 is fraction 4 of
pRPA. Lane 8 is BSA (naturally phosphorylated), a positive control for phosphorylation.
Lane 9 is Lysozyme, a negative control for phosphorylation.
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Fluorescein Imaging
The UV crosslinked DNA-RPA substrate was collected and 10 μl aliquots were mixed with
15 μl of SDS loading buffer and boiled at 90o C for 10 min. The samples were then
electrophoresed on a 15% SDS-polyacrylamide gel, loaded onto a 15% SDSpolyacrylamide and electrophoresed at 60 mA. The gel was then imaged in a Bio-Rad gel
imager with special filters for Fluorescein to visualize bands containing the 5’ 6FAM dt
30mer (Figure 16).
Exhaustive in-gel Digestion
Exhaustive in gel digestion was performed following the protocol of Shevchenko et al.66
Excised gel bands corresponding to the 70, 32, and 14 kDa subunits of RPA and pRPA,
were digested with the serine proteases trypsin and chymotrypsin. Proteomic grade
porcine trypsin (1μg/μl) was used to cleave the carboxyl side of lysines and arginines
and proteomic grade bovine pancreatic chymotrypsin (1μg/μl) was used to cleave the
carboxyl side of leucine, methionine, phenylalanine, tryptophan, and tyrosines. For all
experiments, the protein was digested to exhaustion over night at 37 o C.
The ssDNA:RPA and ssDNA:pRPA covalent adducts were resistant to proteolytic
digestion, and required nucleolytic digestion by Micrococcal nuclease (10 μg
nuclease/100 μg DNA) for 2 hrs. at 37o C prior to proteolysis.
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Figure 16. SDS-polyacrylamide gel of ssDNA photo crosslinked with Human Replication
Protein A. To image RPA covalently crosslinked with 5’ 6 FAM dt 30mer, the Bio-Rad gel
imager was used with the fluoroscein filter. Lane 1 is the Pageruler plus protein ladder.
Lane 2 is ssDNA. Lane 3 is ssDNA treated with 5000 μJ UV. Lane 4 is RPA. Lane 5 is RPA
treated with 5000 μJ UV. Lane 6 is RPA:ssDNA treated with 5,000 μJ UV. Lane 7 is
RPA:ssDNA treated with 5,000 μJ UV and digested with micrococcal nuclease.
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Mass Spectrometry
Mass spectra of RPA, pRPA, and its modified adducts was obtained using a Bruker
Autoflex III MALDI-TOF/TOF mass spectrometer (Bruker Daltonics, Billrica, MA). Prior to
MS analysis, Ziptips™ (c18) were used to remove contaminants and salt as well as
enhance resolution and assignment of peptides. 10 μl of each sample was loaded on the
tips and washed. Increasing concentrations of acetonitrile were used to elute peptides
from Ziptips (c18). Concentrations of 10, 20, 30, 40, 50, 60, 70, 80, 90 and 100%
acetonitrile were used to fractionally elute the peptides bound to the Ziptips. Each
separate elution fraction was spotted and analyzed by mass spectrometry. Fractional
elution provided greater resolution (sequence coverage for RPA) when compared to
single concentration elution of peptides reported in mass spectroscopic analyses. Peaks
corresponding to individual peptides were often present in 1 concentration of
acetonitrile that were not detected in higher or lower concentrations. 1 μl of the eluate
of each wash was mixed with 1 μl of 20 mg/ml CHCA (α-cyano-4-hydroxycinnamic acid).
For each wash, 1 μl of each of the mixtures was spotted on a 384 spot-brushed steel
plate from Bruker Daltonics (Bruker Daltonics, Brillica, MA) and allowed to dry. The
spotted protein was analyzed in the mass spectrometer. Each spot was analyzed with
20,000 laser shots aimed at different random locations in the same spot at 100% laser
intensity with a gain of 15 in reflector mode.
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MMass
Mass spectral data were collected from the Bruker Autoflex III and analyzed
using MMass open source software (MMass.org). Mmass is a software suite that
performs a theoretical digestion of a protein primary sequence and assigns peaks within
the observed spectra to the theoretical digest. Peptides were assigned with a tolerance
of 1,000 ppm. Baseline correction was set to a precision of 5 with a relative offset of 15.
Mass spectral data were smoothed via the Savitzky-Golay algorithm. Peak picking was
performed with a signal to noise threshold of 5.0 and allowing for deisotoping.
Representative results are shown in (Figures 17 & 18). After peak assignment, all data
was compiled into tables showing observed peptides and those amino acids within the
peptides covalently crosslinked to ssDNA (Tables 1, 2, & 3).
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Table 1. Covalently crosslinked amino acids in the 70 kDa subunit of RPA and pRPA.
Residues in the model with a calculated surface exposure of 30% or greater were
considered exposed and colored green. Residues with a calculated surface exposure
between 15-30% were considered partially exposed and colored yellow. Residues with a
calculated surface exposure of less than 15% were considered buried and colored red.
Residues that were the only site for crosslinking in a reported peptide but had a
calculated surface exposure below 15% were colored yellow. For amino acids that were
selected as a direct site of crosslinking, the box adjacent and right was painted blue.
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Table 2. Covalently crosslinked amino acids in the 32 kDa subunit of RPA and pRPA.
Residues in the model with a calculated surface exposure of 30% or greater were
considered exposed and colored green. Residues with a calculated surface exposure
between 15-30% were considered partially exposed and colored yellow. Residues with a
calculated surface exposure of less than 15% were considered buried and colored red.
Residues that were the only site for crosslinking in a reported peptide but had a
calculated surface exposure below 15% were colored yellow. For amino acids that were
selected as a direct site of crosslinking, the box adjacent and right was painted blue.
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Table 3. Covalently crosslinked amino acids in the 14 kDa subunit of RPA and pRPA.
Residues in the model with a calculated surface exposure of 30% or greater were
considered exposed and colored green. Residues with a calculated surface exposure
between 15-30% were considered partially exposed and colored yellow. Residues with a
calculated surface exposure of less than 15% were considered buried and colored red.
Residues that were the only site for crosslinking in a reported peptide but had a
calculated surface exposure below 15% were colored yellow. For amino acids that were
selected as a direct site of crosslinking, the box adjacent and right was painted blue.
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Results
Replication Protein A Purity
To determine the purity of RPA and pRPA, fractions collected from the Q sepharose
column, for RPA and pRPA were electrophoresed on 12% SDS polyacrylamide gels and
visualized with Coomassie Blue gel dye. Bands were visible for both RPA and pRPA at
molecular weights corresponding to 70 kDa, 32 kDa, and 14 kDa (Figures 8 & 9).
Additionally, no contaminant bands that might correspond to truncated protein were
observed. A total of roughly 2 mg of RPA was harvested from each purification.
Activity
To determine the activity of purified RPA and pRPA, binding experiments were
performed in which fluorescence anisotropy was used to monitor association of the
5’6FAM dT30mer with RPA. Concentration dependencies performed under
stoichiometric binding conditions demonstrated approximately 80% of the purified RPA
and pRPA are active in these preparations (Figure 12). SDS gel analysis indicated less
than 5% impurity. Additionally, association constants for hPRA and pRPA binding to the
5’6FAM poly dT30mer were determined by concentration dependancies of
oligonucleotide association with RPA or pRPA. Binding data from multiple runs were fit
to a single site association model using a nonlinear regression analysis implemented on
Slide Write (Sigma Aldrich, St. Louis, MO). Dissociation constants of 1.7x10-9M and
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2.0x10-10M for RPA and pRPA, respectively (Figures 13 & 14) were determined. These
were consistent with previously reported binding experiments49.
Phosphorylation
Upon repurification of RPA subjected to phosphorylation from nuclear extracts from
HeLa cells, samples were electrophoresed on 12% SDS polyacrylamide gels. The gel was
stained with coomassie blue and bands were compared to native RPA to ascertain shifts
in migration corollary to phosphorylation of RPA. Further, the gels were stained with the
phospho-protein specific Pro Q diamond gel stain. The gels demonstrated shifts for the
70 and 32 kDa subunits as well as fluorescence under the Pro Q diamond filters on a Bio
Rad gel imager (Figure 15).
UV Crosslinking
To demonstrate that RPA or pRPA were covalently photo crosslinked to ssDNA
containing a 5’ fluorophor, samples subjected to UV photo crosslinking in the
Stratalinker photo crosslinker were electrophoresed on 15% SDS polyacrylamide gels.
The gels were then imaged in a Bio Rad gel imager with specific filters for the fluorescein
(Figure 16). These gels contained bands that represented the photo crosslinked species
of both RPA and pRPA with the 5’6 FAM dT30mer.
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Mass Spectrometry
RPA, pRPA, ssDNA:RPA, and ssDNA:pRPA, samples were all subjected to mass
spectrometric analyses. Spectra were obtained from individual gel samples of RPA,
pRPA, ssDNA:RPA, and ssDNA:pRPA that were separated via gel electrophoresis and
subjected to exhaustive in-gel proteolytic and nucleolytic digestion. Individual bands,
which represent homogenous samples for the protein, or protein:ssDNA
heteroconjugate were excised and eluted and subsequently spotted for mass spectral
analyses to determine the presence of all peptides corresponding to the 70, 32, and 14
kDa subunits within each sample. Representative results are shown in Figures 17 & 18.
This analysis also ruled out contamination by other proteins within the sample sets as
well as RPA that was not crosslinked for the ssDNA:RPA and ssDNA:pRPA studies.
Further, mass spectroscopic peaks for the N and C termini for the 70, 32, and 14 kDa
subunits were reported. This indicated that each subunit was present in its entirety and
that the subunits were not cleaved or truncated for the modification reactivity analyses.
Discussion
We obtained highly purified RPA, pRPA, ssDNA:RPA, and ssDNA:pRPA. This assertion is
validated by multiple experimental approaches that demonstrates that each preparation
was pure and contained only the desired species of the protein. More so, as proven by
dT30 binding experiments of RPA and pRPA, the protein is highly active. The Kd’s of
1.7x10-9M and 2.0x10-10M correspond to previously reported data for RPA and pRPA
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Figure 17. MMass spectra from covalent crosslink experiments of RPA. Example of
Mother-Daughter peaks from the 14 kDa subunit of RPA corresponding to peptide 85-94
(1231.3472 m/z) and 85-94 crosslinked with ssDNA (1554.3963 m/z).
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Figure 18. MMass spectra from covalent crosslink experiments of pRPA. Example spectra
from 14 kDa subunit of pRPA: DNA showing Mother-Daughter peaks for peptide 88-94
(861.2835 m/z and 1177.6874 m/z).
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with dT30 with values reported at 7.6x10-9M and 6.2x10-9M67, 58, 68 respectively. Taken as
a whole, this suggests that the protein is folded properly and represents the
physiological structure of the RPA in solution. It is with these samples that all
subsequent experiments described here were performed. They provided a solid
foundation for the assessment of covalent photo crosslinking and covalent chemical
modification reactivity analyses with Replication Protein A.
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3. STRUCTURAL ANALYSIS OF HUMAN RPA COVALENTLY PHOTO CROSSLINKED
TO SINGLE STRAND DNA.
Introduction
It is widely believed that RPA has 3 distinct single strand DNA binding modes61.
The first involves small substrates of 8 nucleotides (nt) with low affinity binding, in
which the ligand binds to DBDs A and B. The second is a longer substrate (13-22 nt)
binding mode in which the ligand binds DBDs A, B, and C. While the third is a higher
affinity 30 nt binding mode in which the ligand binds DBDs A, B, C, and D sequentially in
the 5’ to 3’ direction. This attributes binding to only the 70 and 32 kDa subunits of RPA.
While 14 kDa subunit is essential for function of the complete heterotrimer 64, most
proposed models denote the 14 kDa subunit serves exclusively as a structural element.
However, Saintome et al46. reported that the 14 kDa subunit of RPA binds to ssDNA
based on photo crosslinking, EMSA and Western analyses46.
Here we expand upon previous studies by photo crosslinking of ssDNA with
either RPA or phosphorylated human Replication Protein A to determine the specific
peptides and amino acids involved in the direct crosslinking of RPA and pRPA with a
bound 30 nt ssDNA. Measuring the change in mass of crosslinked peptides by mass
spectrometric analysis identifies the amino acids in that are covalently bound with the
crosslinked ssDNA ligand.
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Results
In experiments reported here, peptides in RPA containing crosslinked ssDNA
were identified using mass spectrometry. These peptides contain amino acids that are
theoretical sites of ssDNA crosslinking. For these theoretical sites to be reactive, they
must be exposed and adjacent of the ssDNA. Structural models provide exposure
information for the crystalline protein, but more specifically for the OB folds (putative
sites for ssDNA binding) as well as other domain regions within the protein. Therefore,
theoretical crosslinking sites in peptides which were identified as being crosslinked by
reported mass spectrometry data, were identified (localized) in RPA structural models
(Figure 19). Not all theoretical sites need to be in a ssDNA binding site. In fact, if one of
several theoretical sites is within a nucleotide binding site, the crosslinking result is
explained. If a residue is exposed in a protein model and outside a previously identified
ssDNA binding site, yet must be reactive to explain crosslinking results, it may indicate a
novel ssDNA binding site.
Assignment of crosslinking to a specific amino acid in a peptide from the mass
spectrometric data was informed by the solvent accessible surface area of the amino
acid in both the crystallographicly derived 3KDF model (corresponding to the 14 and 32
kDa subunits) and the M80PS model proposed by our lab 8 (model for the full structure
of RPA in the apo state). To rule out multiple reaction sites within one peptide, peptides
corresponding to missed cut sites both immediately before or after the peptide
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containing the amino acid in question were used determine the reactivity of amino acids
on either side of the amino acid of interest. Data corresponding to reported mass
spectra for covalently crosslinked amino acids in RPA and pRPA were placed into tables
to compare the
Figure 19. Ribbon model of M80PS. The Domains are colored according to the previous
scheme (Figure 2) and amino acids covalently crosslinked with ssDNA are colored green,
while phosphorylated amino acids were colored orange.
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assigned sites of crosslinking to the proposed surface accessibility of the crosslinked
amino acid in the M80PS model (Tables 1, 2, & 3).
Evaluation of ssDNA crosslinked with RPA
Data summarized in tables 1-3 were used to paint the x-ray crystallographicly
derived model, 3KDF, which includes RPA’s 14 and 32 kDa subunits, resolution of 1.98Å
(Figure 20). Model-dependent surface-exposure evaluation of amino acids covalently
crosslinked to ssDNA allowed the identification of the most probable targeted amino
acids within the corresponding models. By using in vitro experimentation, we either
supported or refuted the position of the amino acid under the specific reaction
conditions for the proposed model based on actual experimental data. 3KDF was
selected as it is a minimal structure that represents a truncated species of RPA
containing DBD E of the 14 kDa subunit. Surface exposure models corresponding to
3KDF were also evaluated (Figure 21). The amino acids that were then chosen as
candidate residues were painted green on the 3KDF structure of ribbon and surface
models (Figs. 19 & 20). The data summarized in tables 1-3 were then used to paint
M80PS ribbon and surface models of RPA proposed by Nuss et al (Figures 22 & 23,
Tables 1, 2, & 3)8. This model was selected as it is a full structural model of RPA
containing all amino acids, DBDs and subunits. To determine which amino acid within a
peptide of interest was the most likely candidate for crosslinking, each amino acid
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Figure 20. Ribbon model of 3KDF crystal structure painted according to scheme (Figure
2) demonstrating targeted amino acids for ssDNA binding for both RPA and pRPA.
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Figure 21. Surface model of 3KDF crystal structure painted according to scheme (Figure
2) demonstrating targeted amino acids for ssDNA binding for both RPA and pRPA.
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Figure 22. Ribbon models of M80PS of RPA and pRPA colored according to scheme
(Figure 2) with covalently crosslinked amino acids. The putative binding sites are colored
orange and covalently crosslinked amino acids colored in green.
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Figure 23. Surface models of M80PS of RPA and pRPA colored according to scheme
(Figure 2) with covalently crosslinked amino acids colored in green.
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within a crosslinked peptide was evaluated based on calculated surface exposures, as
determined through SPDBV software. Amino acids with a score of 30% or greater
corresponded to exposed, as they represent enough of the amino acid projecting
outward or on the surface of the protein to have interactions with chemical modifying
reagents, those with a score of 15-30% corresponded to partially buried and were also
selected as having enough surface exposure to react with chemical modifying reagents,
and were chosen as candidate amino acids for the reactions8. Amino acids with less than
15% exposure are considered buried and ruled out for the sake of this analysis. All
interacting amino acids for the 70, 32, and 14 kDa subunits were evaluated based on the
M80PS model. Again, the same criterion for selection, as based on predicted surface
exposure was used to determine which amino acids were buried or exposed. Candidate
amino acids were painted green on the model. Additionally, for the M80PS model, DBDs
A & B were removed to show structural detail of the 14 kDa subunit within the models
(Figures 24 & 25).

87

Figure 24. Ribbon models of M80PS of RPA and pRPA colored according to scheme
(Figure 2) with putative binding sites colored orange, covalently crosslinked amino acids
colored in green and DBDs A and B removed.
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Figure 25. Surface models of M80PS of RPA and pRPA colored according to scheme
(Figure 2) with putative binding sites colored orange, covalently crosslinked amino acids
colored in green and DBDs A and B removed.
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Covalently Crosslinked Amino Acids in the 70 and 32 kDa subunits
Lysine, phenylalanine, tryptophan, and tyrosine are the primary reactive sites for
photo crosslinking with the single strand thymidine 30 mer69. All peptides corresponding
to covalently crosslinked ssDNA:RPA heteroconjugates contained these predicted target
amino acids. Potential targets were selected as specific amino acids capable of
covalently photo crosslinking with the ssDNA poly T 30mer within the observed peptide
that contained a photo crosslink. When there was a covalent crosslink between ssDNA
and a peptide and only 1 amino acid corresponded to those capable of crosslinking to
ssDNA, then an assignment was made. When the data indicated a covalent crosslink
within a peptide and there were 2 or more amino acids within the peptide capable of
crosslinking with the ssDNA, we used several factors for the tentative identification of
the bound amino acid. The first was to look at physical placement and surface exposure
of the amino acids as based on the M80PS model. Those with surface exposures less
than 15% were ruled out based on previous experimental protocol8. Amino acids that
were in putative binding sites were of higher preference, as they were a more probable
candidate amino acid than one on the back side of a binding pocket. The second was to
look at peptides containing the amino acids of interest for the parallel experiment using
a different protease. Many times, amino acids could be separated and reactivity
identified based on the presence or absence of a crosslink in a peptide that contained 1,
but not both of the ambiguous amino acids in the other experiment. The third was to
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look at peptides within the same experiment that corresponded to missed cut sites and
contained potential amino acids on either side of the most likely target for the reaction.
Again, the reactivity of a particular amino acid, could be separated from the other in
question. However, not all amino acid candidates for a specific crosslinking reaction
could be assigned. In that case, both amino acids were considered potential targets for
the reaction. The criterion for the assigned targets primarily corresponded to the amino
acids within the potential target pool that were within the ssDNA binding groove of a
DNA binding site of the subunit and have surface exposures above the 15% threshold
necessary for the photo crosslinking reaction (Tables 1 & 2). In some instances, peptides
containing a covalent ssDNA crosslink were outside of putative binding sites. Again, the
selection criteria previously mentioned was used to determine which amino acids were
the most likely candidate if more than 1 potential target was within the peptide.
When evaluating data from ssDNA:RPA, there were 58 candidate amino acids in
the 70 kDa subunit of RPA covalently crosslinked with ssDNA (Table 1). Of those 58
candidates, 41 were assigned as targets for crosslinking. Amino acids that were not
chosen were in portions of the peptide that were outside the reported DBDs for each
subunit or were in portions of the protein that were not accessible for interaction based
on the structural models of the protein. In the 70 kDa subunit of the ssDNA:pRPA
heteroconjugate, there were 53 candidate amino acids, 41 of which were selected as
targeted amino acids for covalent crosslinking (Table 1). In the N terminus of the 70 kDa
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subunit of RPA and the adjacent linker region connecting DBD F to DBD A, there were 4
covalently crosslinked amino acids that were not present in the ssDNA:pRPA
heterconjugate (42, 88, 103, and 111). Of the remaining discrepancies between the
ssDNA:RPA heteroconjugate and the ssDNA:pRPA heteroconjugate, the specific amino
acid targets coincided with peptides that are parts of DBDs A, B, &C, and are within the
same DBDs in the 70 kDa subunit (Table 1) residues 222, 253, 280, 302, 379,528, 532,
and 567. The minor variations between bound amino acids appear to represent local
structural changes within these subdomain regions.
In the 32 kDa subunit of the ssDNA:RPA heteroconjugate, there were 15
candidate amino acids, of which, 12 were selected as amino acids is predicted
interaction sites (Table 2). Again, amino acids that were not chosen were in portions of
the peptide that were outside the reported DBDs for each subunit or were in portions of
the protein that were not accessible for interaction based on the structural models of
the protein. In the 32 kDa subunit of the ssDNA:pRPA heteroconjugate, there were 21
candidate amino acids, with 18 being selected as amino acids in predicted interaction
sites (Table 2). The ssDNA:pRPA heteroconjugate contained 5 amino acid targets within
the N-terminal region that were not present in the native ssDNA:RPA heteronconjugate
(residues 2, 6, 9, 14, and 20). Additionally, 3 amino acids, (155, 171, and 194) were
selected as targets in ssDNA:pRPA that were not present in ssDNA:RPA.
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Covalently Crosslinked Amino Acids in the 14 kDa Subunit
Within the 14 kDa subunit of RPA in the 3KDF model, there were 9 amino acids
within the peptides that were covalently crosslinked, of those 6 were selected as amino
acids within predicted interaction sites, with at least 1 being present in each peptide
with a surface exposure greater than 15% (Table 3). Within the 14 kDa subunit of pRPA
in the 3KDF model, there were 11 amino acids within the peptides that were covalently
crosslinked, of those 7 met the selection criteria as amino acids within predicted
interaction sites, with at least 1 being present in each peptide with a surface exposure
greater than 15% (Table 3). 9 amino acids were present in the 14 kDa subunit of RPA for
the M80PS model. Again, 6 were selected as target amino acids (Table 3). 5 of the
targeted amino acids had surface exposures of 15% or higher, and 1 amino acid (residue
104) corresponded as a buried amino acid within the M80PS, but was the only target
amino acid within the peptide. 12 amino acids were present in peptides within the 14
kDa subunit of pRPA for the M80PS model. 6 amino acids were selected as covalently
crosslinked amino acids (Table 3). 5 of the targeted amino acids had surface exposures
greater than 15% and 1 amino acids were scored as buried, but was the only targeted
amino acid within the covalently crosslinked peptide (residue 104). While both RPA and
pRPA have 6 targeted amino acids, 3 of which differ between the 2 states. In RPA K 33
and K 39 are targets, but are not covalently crosslinked in pRPA (Table 3). Likewise, K 76
is covalently crosslinked in pRPA but not in RPA (Table 3). This suggests that the portion
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of DBD E that is accessible for the interaction varies between the 2 states, and suggests
conformational differences between the two structures resulting from the
phosphorylation, or potentially represents the rearrangement of domains within the
protein between the two reaction states. It should be noted, that 4 of the 6 amino acid
targets are the same, and that the differences could represent a marginal
rearrangement of the DBD between the 2 states.
Discussion
Single strand DNA binding activity involving the 70 and 32 kDa subunits of RPA is
well known with established binding affinities for each DBD within the subunits30. With
the exception of the covalently crosslinked amino acids of DBD F of the N-terminus of
the 70 kDa subunit of ssDNA:RPA, and the N terminal amino acids of the 32 kDa subunit
of ssDNA:pRPA, there were only minor differences between the target amino acids
covalently crosslinked in the native and phosphorylated states of the protein. However,
ssDNA crosslinking involving DBD F of RPA was unexpected. It implies that DBD F is in
close proximity to the ssDNA substrate and in a conformation that places the ssDNA
near the binding pocket of DBD F. This is consistent with the M80PS model which has
the putative binding site in DBD F closely positioned to DBD D in the 32 kDa subunit. In
the ssDNA:pRPA heteroconjugate, the absence of binding in this region suggests that
the binding pocket of DBD F is occluded or juxtaposed away from the ssDNA substrate.
The opposite is true for the binding of the N terminus of the 32 kDa subunit. Binding of
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the 32 N terminus in pRPA to ssDNA necessitates that this region of the phosphorylated
species lies in proximity to ssDNA and presents the adjacent binding pocket of DBD D for
this reaction. The absence of binding in the unphosphorylated species suggests that this
region does not present favorable amino acids for the covalent crosslinking reaction.
The individual differences in the remaining data points in both the 70 kDa subunit and
the 32 kDa subunit could represent minor local changes in each binding site that are
affected by changes in local position of amino acids or potentially represent differing
electrostatic potential of the phosphorylated protein versus the native protein. As a
whole, this data fits traditional models and corresponded to previously reported DNA
binding sites for the subunits70.
Currently, the 3 proposed modes of binding for RPA to ssDNA are for varying
lengths of substrates, and progress in the 5’-3’ direction starting with the DBD A of the
70 kDa subunit and progress through DBDs B and C then to DBD D of the 32 kDa
subunit5. Here we show direct covalent crosslinking of ssDNA with the DBD E of the 14
kDa subunit. This interaction gives insight into the juxtaposition of the 70 kDa subunit
with respect to the 14 kDa subunit. In a proposed model of apo RPA by Nuss et al.8, the
DBDs A and B of the 70 kDa subunit are tethered to the trimerization core and occlude
the nucleotide binding site of the 14 kDa subunit. Our results, reported here, provide an
insight into potential structural rearrangements of the high affinity DBDs A & B in RPA
and pRPA, which would allow these domains to undock from or reposition on the
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trimerization core, thus freeing DBD E, of the 14 kDa subunit of RPA, for binding to a 30
nt ligand. Removing DBDs A & B of the 70 kDa subunit from the M80PS model
demonstrated the accessibility of the 14 kDa subunit when these DBDs are not directly
juxtaposed to the trimerization core. With the removal of DBDs A & B, DBD E of the 14
kDa subunit is directly accessible for interaction with ssDNA (Figures 24 & 25). More
specifically, the amino acids covalently photo crosslinked to ssDNA are within the β
barrel of DBD E and the α-helix proximal to it, which represent the putative binding site
on the DBD (Figure 22). This suggests that a structural rearrangement from the unbound
molecule to the bound state is necessary. This is consistent with the positioning of the A
& B domains in a crystal structure of the RPA homologue in U. maydis proposed by
Pavletich et al71, as well as structural models proposed by the Chazin lab,72. It further
demonstrates the role of the 14 kDa subunit, while essential for the formation of the
protein, surpasses a solely structural relationship to the 70 and 32 kDa subunits. The
evolutionary conservation of the DBD E within the 14 kDa subunit in all RPA homologues
again suggest that this portion of the protein is more than structural in nature73. Direct
binding of the 14 kDa subunit implies a 4th mode of binding, or at the very least a
modified 3rd mode for the full length 30 nt ligand. The putative binding site on DBD E is
positioned opposite from DBD D of the 32 kDa subunit. The distance separating DBDs C
& D and DBD E of the 14 kDa subunit would prevent a ligand of 30 nt in length from
simultaneously binding DBDs A, B, C, D and E. This suggests that DBD E might bind
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ssDNA independently of the previously reported mode in which a 30 nt ligand
concurrently binds DBDs A, B, C, and D. In further support of this independent mode of
binding, is the placement of DBD C. DBD C lies between the putative binding sites of
DBD D and DBD E. The ssDNA ligand would have to bend around the molecule to
simultaneously bind DBD C, D, and E, which strays from the traditional belief that the
ssDNA ligand is straight and does not conform to the structure of RPA 74.
Phosphorylated RPA serves a different function within the cell from that of the
unphosphorylated protein49. It is involved in DNA damage repair, while the
unphosphorylated heterotrimer is involved in DNA replication and check point
signalling6. Phosphorylation involves the N terminus of the 32 kDa subunit, as well as
portions of the 70 kDa subunit48. Investigators have suggested that this phosphorylation
leads to an extended conformation for the amino acids within these regions of the
protein48. This structural rearrangement may cause minor perturbations within the 14
kDa subunit as well. This is suggested by the differing peptides that are available for
covalent photo crosslinking of the 30 nt ligand in the N terminus of the 70 kDa subunit
of RPA, as well as the N terminus of the 32 kDa subunit of pRPA which are in close
proximity to DBD E on the 14 kDa subunit.
The data reported here cannot accommodate current models for the structure of
phosphorylated. Local rearrangement of DBDs is necessary to explain the reactions with
amino acids that are buried within the reported structures. Specifically, rearrangement
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of amino acids in DBD F as well as the N terminus of the 32 kDa subunit would more
accurately fit our experimental data.
While it is clear that RPA plays a vital role in DNA regulation, maintenance, and
repair, the role of the 14 kDa subunit remains uncertain. Demonstration of the 14 kDa’s
ability to bind to ssDNA suggests that there may be a physiological role for this subunit
that remains to be determined5,52. Attachment of ssDNA with DBD E of the 14 kDa
subunit would aid continuing processivity of the molecule through replication.
Additionally, this attachment would provide greater adhesion to the DNA if the Nterminus of 70 interacts with p53 in the DBD F of the 70 kDa subunit in the presence of
DNA damage75. Binding of DBD E would allow DBD A and DBD B to detach and bind to
different sites along the DNA strand without detaching the heterotrimer from the DNA.
The data reported here extended the work of Saintome et al.46 We demonstrated
the interaction of the 14 kDa subunit with ssDNA in RPA and pRPA. Further, we
identified the direct sites amino acid ssDNA binding within DBD E for both RPA and
pRPA. The amino acids reported as binding to ssDNA were within the OB fold of the
putative binding site of DBD E. This is consistent with ssDNA binding in the OB folds of
DBDs A, B, C, and D.
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4. STRUCTURAL ANALYSIS OF HUMAN REPLICATION PROTEIN A AND
PHOSPHORYLATED HUMAN REPLICATION PROTEIN THROUGH CHEMICAL
MODIFICATION REACTIVITY ANLAYSIS AND COVALENT PHOTO CROSSLINKING OF
SINGLE STRAND DNA
Introduction
RPA is relatively large (116 kDa) and contains regions classified as inherently
unstructured that link multiple domains within the protein71 (Figure 26). These
characteristics limit the ability to determine the full heterotrimeric structures of RPA by
x-ray crystallography and NMR. While it is believed that binding DNA causes structural
rearrangement of RPA, many of the changes are still vague72,43. More so, structural
rearrangement of the molecule in the phosphorylated state is also poorly understood6.
To address this problem, an extensive literature and structural search was conducted to
determine a list of areas of subunit-subunit and domain-domain interactions identified
in select available crystal and NMR structures of Replication Protein A
fragments71,72,76,60,19. Here, through the use of direct in vitro experimentation by
chemical modification reactivity analyses, we evaluated the sites of subunit-subunit and
domain interaction for RPA and pRPA in ssDNA free and ssDNA bound reactive states.
Results
RPA structural models reported from all available crystal and NMR structural
studies for Replication Protein A were used to identify regions of subunit and domain
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Figure 26. Structural model of RPA. The view of the structural model in the right panel is
o

rotated 90 about a vertical axis relative to the left panel view. Domains are indicated by
tubes. The α-trace of non-domain regions generated by simulated annealing are
represented as stick figures.
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surfaces involved in subunit-subunit and domain-domain interactions. Specifically,
aspartates, glutamates, and lysines that reside within the portions of the models that
are involved in subunit-subunit and domain-domain interactions were then probed by in
vitro chemical modification (Table 4). The chemical modification reactivity of these
amino acids were then evaluated on a kinetic basis to determine susceptibility and rate
of modification, which provided greater detail for the reactions of the amino acids in the
inter subunit and inter domain interacting sites (Table 4). Evaluating the chemical
modification reactivity data allowed us to infer conformational changes in the protein’s
structure. While all reported crystal and NMR structures were used to determine the list
of amino acids for MRAN, none of these structures correspond to the full native or
phosphorylated protein. Therefore, choosing of the amino acids for this study was
primarily informed by a structural model proposed by Nuss et al8., (Figure 2). This model
was built in an additive process in which a core structure was assembled, and remaining
domains and inter domain sequences were placed so their position was consistent with
chemical modification results and docking free energy calculations previously reported8.
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The resulting data from chemical modifications in this study was then used to
judge the relevance of the reported three dimensional models of human Replication
Protein A (Figure 27). Relevant fit of the residues in the proposed structures were
evaluated on the basis of its reactivity relative to its surface accessibility and exposure in
the structural model. X-ray crystal and NMR structures were evaluated on a residue by
residue basis to determine if experimental data coincided with the proposed structures.
The models that were most consistent with experimental data were selected. Further,
the data suggested how a selected model could be altered to conform to modification
results and more accurately describe the residue and molecule in solution state. The
data for these models was collected for each residue when RPA was in several
physiologically important states including: native, phosphorylated, bound with ssDNA,
and phosphorylated and bound with ssDNA.
The previous studies identifying ssDNA binding sites (Chapter 3 in this
dissertation) suggest changes in packing of DBD A and DBD B concomitant with DNA
binding in the complete protein. Yet, it provides no information about novel interaction
sites of these domains with the rest of the protein10,77. More so, for the other DNA
binding domains of RPA, (C, D, E, & F), the structure of the domains in RPA fragments
has not been reported in the presence of DNA, though they have in its absence 19,43. Our
lab has proposed the full structure of RPA in the absence of ssDNA8, and suggested
interactions between all domains in this state. Understanding the interactions of these
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Figure 27. Ribbon model M80PS. Domains are colored according to the previous scheme
(Figure 2), while aspartates, glutamates, and lysines that were covalently chemically
modified by EDC glycine methyl ester or sulfo-NHS-acetate were colored magenta.
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Table 4. Kinetic evaluation of residues of interest and amino acids in inter domain and
inter subunit sites for the 70, 32, and 14 kDa subunits of RPA.
Very Reactive residues were colored green. Reactive residues were colored yellow.
Unreactive residues were colored red. Sites where there was no data for a reaction was
colored white.
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Subunit
14
14
14
14
14
14
14
14
14
14
14
14
14

AA
3
22
23
33
45
49
54
57
68
76
95
104
108

RPA
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
unreactive
reactive

ssDNA:RPA
reactive
unreactive
reactive
reactive
reactive
unreactive
reactive
reactive
reactive
reactive
unreactive
reactive
reactive
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pRPA
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
unreactive
reactive

ssDNA:pRPA
reactive
unreactive
reactive
reactive
reactive
unreactive
reactive
reactive
reactive
reactive
unreactive
reactive
Reactive

Subunit
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32

AA
7
36
37
38
62
70
84
85
95
96
103
111
112
127
139
145
151
154
171
217
223
229
231
235
243
247
252
260
261
262
265
268
270

RPA
very reactive
reactive
no data
no data
reactive
reactive
reactive
very reactive
reactive
reactive
reactive
reactive
reactive
very reactive
reactive
unreactive
unreactive
unreactive
very reactive
unreactive
reactive
reactive
unreactive
reactive
reactive
reactive
reactive
very reactive
very reactive
very reactive
very reactive
very reactive
very reactive

ssDNA:RPA
reactive
no data
no data
no data
reactive
reactive
reactive
reactive
unreactive
unreactive
unreactive
reactive
reactive
very reactive
reactive
no data
unreactive
unreactive
very reactive
no data
reactive
reactive
very reactive
very reactive
very reactive
reactive
unreactive
reactive
reactive
reactive
no data
reactive
reactive
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pRPA
reactive
no data
very reactive
very reactive
reactive
unreactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
very reactive
reactive
no data
unreactive
unreactive
very reactive
no data
very reactive
unreactive
no data
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive

ssDNA:pRPA
reactive
no data
no data
no data
reactive
reactive
reactive
unreactive
reactive
reactive
reactive
reactive
reactive
no data
reactive
no data
reactive
reactive
very reactive
no data
very reactive
reactive
no data
no data
no data
reactive
reactive
reactive
reactive
reactive
no data
reactive
Reactive

Subunit
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70
70

AA
7
16
18
23
48
67
68
69
88
89
98
100
103
106
111
183
229
230
259
263
277
290
307
309
318
343
354
404
406
410
416
418
429
469
489
501
551
555
577
588

RPA
very reactive
reactive
reactive
very reactive
very reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
unreactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive

ssDNA:RPA
very reactive
no data
reactive
no data
reactive
reactive
reactive
reactive
no data
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
unreactive
reactive
reactive
unreactive
reactive
reactive
no data
no data
reactive
reactive
reactive
reactive
reactive
reactive
unreactive
unreactive
reactive
no data
reactive
unreactive
unreactive

111

pRPA
very reactive
reactive
reactive
very reactive
reactive
reactive
reactive
reactive
no data
very reactive
reactive
unreactive
no data
reactive
no data
reactive
reactive
reactive
reactive
reactive
reactive
reactive
unreactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
unreactive
no data
reactive
no data
reactive
reactive
no data

ssDNA:pRPA
very reactive
Reactive
reactive
very reactive
reactive
reactive
reactive
reactive
no data
reactive
very reactive
reactive
reactive
reactive
reactive
no data
reactive
reactive
reactive
unreactive
reactive
no data
reactive
reactive
reactive
unreactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
reactive
no data
reactive
no data
reactive
very reactive
reactive

domains in the presence of ssDNA will provide greater insight into the arrangement of
the molecule and suggests how that arrangement modulates the protein’s function
when RPA is bound to DNA. To evaluate this RPA state, a list of potential amino acid
targets in these regions is of particular interest since any rearrangement of domains
would presumably change these amino acids’ reactivity. In addition, potential target
amino acids in DNA binding sites are of interest since their reactivity should change in
the presence of bound DNA, if only by being bound to DNA.
To assure that all appropriate RPA and pRPA nucleotide binding sites were
occupied by ssDNA throughout modification reactivity analyses, we covalently photo
crosslinked ssDNA 5’6FAM poly T 30mer to RPA or pRPA. Isolating these RPA or pRPAssDNA adducts assured that only protein containing ssDNA was used in experiments.
These covalently bound protein-nucleotide heteroconjugates were used for covalent
chemical modification experiments designed to probe the structure of ssDNA bound
RPA and ssDNA bound pRPA78. To determine sites of heteroconjugate formation as well
as identify amino acids that were covalently modified via MRAN in these experiments,
SDS polyacrylamide electrophoresis and in gel digestion was used in conjunction with
mass spectrometry to determine the locations of ssDNA binding and to evaluate the
chemical reactivity of the amino acids selected in the inter domain interacting sites and
infer structural differences among the various ligand binding sites under differing
experimental conditions.
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Data assessment and pairwise comparison tables
Reaction products were analyzed using mass spectroscopy. Spectra results were
evaluated using Mmass software (MMass.org) and results were used to create a series
of tables in which covalent photo-crosslinking, covalent chemical modification, and
phosphorylation states were compared among the different RPA ligand binding states.
Chemical modification of the aspartates, glutamates, and lysines within peptides within
in the 70, 32, and 14 kDa subunit interaction sites of RPA and pRPA were determined.
Lysines covalently chemically modified by sulfo-NHS acetate increased their mass by 42
daltons64. Peptides containing aspartates and glutamates and modified by EDC and
glycine methyl ester increased their mass by 124 daltons for each amino acid covalently
chemically modified62. The change in mass between the native unmodified peptide to
that of a chemically modified peptide, as ascertained via mass spectrometry, was then
used to identify each amino acid that was modified in the peptide. Photo crosslinking of
ssDNA polyT 30mer resulted in a net gain of 321 daltons for each thymidine that was
covalently crosslinked with an amino acid within the peptide27. Lastly, phosphorylation
of serines and threonines within the 70, 32, and 14 kDa subunits of phosphorylated RPA
was identified. Phosphorylation of serines and threonines resulted in a net increase of
80 daltons for each amino acid that was modified in a peptide48. Methionine and
tryrosine residues are also potential targets of phosphorylation, but were not found
within the spectra collected27. The data collected for the measured reactivities and
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modifications were then organized into pairwise comparison tables for direct
comparison of chemical modifications, phosphorylations, and covalent crosslinks of
ssDNA between RPA and ssDNA:RPA (Table 8), pRPA and ssDNA:pRPA (Table 9), RPA and
pRPA (Table 10), and ssDNA:RPA and ssDNA:pRPA (Table 11). Additionally, a table was
created that compared the predicted surface exposure of amino acids in crystal,
NMR, and proposed models of RPA to evaluate the relevance of those models to the
modification results reported here (Table 5 & 6).
The surface exposure for each modified amino acid was calculated using SPDBV
for the crystal, and NMR structures corresponding to fragments of RPA. Specifically,
1JMC, 1L1O, 1FGU, 1DPU, 3KDF, 1EWI, 4R4C, M80PS, and 4GNX were used. The tables
for chemical reactivity, photo crosslinking, and phosphorylation were then compared to
calculated surface exposure to ascertain whether the model fit the reported
experimental data as well as what changes are necessary for the model to account for
differences between the model and experimental data.

Kinetic evaluation of MRAN analyses of Replication Protein A
Even with a single-time measurement of a chemical modification reaction,
(rather than a full time course), it is possible to classify reactions in one of three
categories, on the basis of kinetics. If only the product was found then the reaction was
fast relative to the time of observation and was scored very reactive, if only the
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reactants were found then the reaction is slow, relative to the observation time and was
scored unreactive, and if both product and reactant were observed, then the reaction
proceeds at an intermediate rate and was scored reactive. It follows, that if multiple
reactions are measured at the same time under identical conditions, these reactions can
be grouped in the categories just mentioned and compared with each other. A rubric
was established to score the reactivities of individual amino acids within a peptide
(Table 12). Relative signal intensity in mass spectrometry depends on several molecular
characteristics other than relative molar quantity. In fact, specific products or reactants
might not be observed under particular instrumental conditions. Since chemical
modification changes these features, it is risky to quantify reactions based on relative
amplitudes. However, the presence of mass spectral peaks indicating the presence or
reactant, product, or both still allows for the classification scheme just described.
Number of very reactive, reactive, and nonreactive sites in a peptide A
complication occurs in measuring the reaction of peptides, as is done here, rather than
individual amino acids. If multiple reactions occur in the peptide, then multiple products
are expected. With the assumption that reactions occur at each site in the protein
independently, the expected products will simply be the sum of those expected at each
reactive/potentially reactive site (i.e. for a peptide with two reactive sites, mass peaks
corresponding to two modification, one modification, or no modification might be
produced). In addition, the most conservative application of this analysis should also
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allow that an expected MS peak might not be seen because the corresponding peptide
“did not fly”, or has a charge (negative) inconsistent with acceleration and detection
systems of the mass spectrometer. Based on the considerations just described, we
predicted which molecular species would be produced (and corresponding mass
spectral peaks seen) if a peptide generated by cleavage of a protein previously modified
by a reagent contains one, two, three, four, or more modification sites, assuming that
each modification site can be very reactive, unreactive, or moderately reactive . If one
or more products predicted for a particular extent of modification was observed this
extent of modification was considered a potential product (group of products). If more
than one extent of modification was found then these were all considered as possible
products.
Assignment of a reactivity to a single amino acids
When multiple modification sites occur in a single peptide, and the analysis just
described indicated that a specific number of very reactive, reactive, and unreactive
sites were present, assignment of a reactivity class to a particular amino acid frequently
required considering the reactivities of neighboring peptides in the primary structure.
Neighboring peptides can often contain 1 or more of the amino acid targets for chemical
modification that are within the peptide of interest. By determining the reactivity of
these amino acids independently from the peptide containing the amino acids of
interest, the reaction
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Table 5. Comparison of chemical modification reactivity data for the EDC glycine methyl
ester reaction to the proposed models.
Corresponding data reported here for the M80PS structure, as well as reported crystal,
and NMR models for fragments of RPA are shown. The listed structure is placed under
each reaction that corresponds to a match with its available surface exposure and the
reported result from chemical modification reactivity analyses. Residues within a
structure with a surface accessibility of 30% or higher (considered reactive for this study)
were colored green. Residues within a structure with a surface accessibility between 1530% (considered reactive for this study) were colored yellow. Residues within a structure
with a surface exposure below 15% (considered unreactive for this study) were colored
red. As 4GNX is the structure of a human RPA homologue from U.maydis, not all residues
were the same, and therefore were not targets for chemical modification. When U.
maydis did not have a homologous aspartate, glutamate, or lysine it was noted in blue.
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Table 6. Comparison of chemical modification reactivity data for the sulfo-NHS-acetate
reaction to the proposed models.
Corresponding data reported here for the M80PS structure, as well as reported crystal,
and NMR models for fragments of RPA are shown. The listed structure is placed under
each reaction that corresponds to a match with its available surface exposure and the
reported result from chemical modification reactivity analyses. Residues within a
structure with a surface accessibility of 30% or higher (considered reactive for this study)
were colored green. Residues within a structure with a surface accessibility between 1530% (considered reactive for this study) were colored yellow. Residues within a structure
with a surface exposure below 15% (considered unreactive for this study) were colored
red. As 4GNX is the structure of a human RPA homologue from U.maydis, not all residues
were the same, and therefore were not targets for chemical modification. When U.
maydis did not have a homologous aspartate, glutamate, or lysine it was noted in blue.
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products for the chemical modification of the peptide of interest can be separated. A
unique amino acid assignment was frequently found in this way. Even when a complete
assignment cannot be made, some possibilities are often eliminated. When multiple
targets occurred in a peptide, which analysis indicated had different reactivities, the
assignment of reactivities to specific residues also took into consideration predicted
surface exposures for the amino acids in various structural models. The models used to
select the amino acids included the M80PS model, produced in our laboratory8, 1JMC
(which is a crystal structure of DBDs A & B, of the 70 kDa subunit, bound to ssDNA),
1DPU (the C terminus of the 32 kDa subunit), and 1L1O (the trimerization core of RPA,
consisting of the 14 kDa subunit, a truncated 32 kDa subunit missing the N and C
termini, and DBD C on the C terminus of the 70 kDa subunit).
This method was then used to measure the chemical modification reactive states
of the inter domain interaction sites between DBDs A & B, as well as the N terminus of
the 70 kDa subunit to better understand the positioning of DBDs A & B and the N
terminus of the 70 kDa subunit on the surface of the trimerization core, which contains
DBDs C, D and E (Table 4).
Modified Residue Structural Comparisons
Comparisons of the reactivity of the same RPA residues when the protein is in
different DNA binding and phosphorylation states are summarized in the pairwise
comparison tables (Tables 8, 9, 10, & 11). Reactivities were judged using the previously
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mentioned criterion for a reaction with a modifying. A residue by residue classification
for each reaction state was used to determine whether any structural changes occurred
between the various RPA ligand binding states. A total of 48 reactive amino acids were
probed in the 3 subunits of RPA, 8 of which were in the 14 kDa subunit, 12 were in the
32 kDa subunit, and 28 were in the 70 kDa subunit (Table 7).
RPA vs ssDNA:RPA
In comparing RPA and ssDNA:RPA (Table 8), the 14 kDa subunit had 2 amino
acids, aspartate 22 and lysine 49, which were modified in RPA but were not modified in
the ssDNA:RPA (Figures 28 & 29). The 32 kDa subunit contained 1 amino acid that had
differing reactivity between the 2 states, aspartate 103. In RPA, aspartate 103 was
modified, however, no modification occurred when DNA was bound. In the 70 kDa
subunit lysine 88, lysine 263, lysine 273, lysine 379, and aspartate 307 were modified in
the RPA, but not in ssDNA:RPA.
pRPA vs ssDNA:pRPA
In the comparison between the pRPA and ssDNA:pRPA, (Table 9), again,
aspartate 22 and lysine 49, in the 14 kDa subunit, were modified in pRPA and were not
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Table 7. Residues of Interest for the 14, 32, and 70 kDa subunits of Human Replication
Protein A.
These residues were the primary residues probed in the pairwise comparison tables
between the different RPA reactive states.

125

Subunit
14

Glu/Asp
3
22
54
57

Lys
23
33
49
76

32

7
36
62
70
84
103
111
112
261
270

85
171

70

68
229
230
290
307
309
404
407
416
418
469
501
555

88
111
183
244
257
264
273
313
341
354
379
410
467
481
498
551

126

Table 8. Comparison of chemical modification reactivities between native RPA and
ssDNA:RPA.
Amino acids that were chemically modified were colored green Amino acids that were
not modified were colored red. Amino acids that were crosslinked to ssDNA only were
colored blue. Sites were there was no data for an amino acid was colored white.
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Table 9. Comparison of chemical modification reactivities between pRPA and
ssDNA:pRPA.
Amino acids that were chemically modified were colored green Amino acids that were
not modified were colored red. Amino acids that were crosslinked to ssDNA only were
colored blue. Sites were there was no data for an amino acid was colored white.
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Table 10. Comparison of chemical modification reactivities between RPA and pRPA.
Amino acids that were chemically modified were colored green Amino acids that were
not modified were colored red. Amino acids that were crosslinked to ssDNA only were
colored blue. Sites were there was no data for an amino acid was colored white.
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Table 11. Comparison of chemical modification reactivities between ssDNA:RPA and
ssDNA:pRPA.
Amino acids that were chemically modified were colored green Amino acids that were
not modified were colored red. Amino acids that were crosslinked to ssDNA only were
colored blue. Sites were there was no data for an amino acid was colored white.
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Figure 28. View of Lys 49 in the putative binding site of the 14 kDa subunit in the M80PS
ribbon model. Domains are colored according to the previous scheme (Figure 2). This
residue is blocked by DBD B in the native state, but is covalently crosslinked to ssDNA in
the bound state.
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Figure 29. View of Asp 22 in the putative binding site of the 14 kDa subunit in the M80PS
ribbon model. Domains are colored according to the previous scheme (Figure 2). Asp 22
is blocked by DBD A in the native state, but is covalently crosslinked to ssDNA in the
bound state.
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Figure 30. View of Glu 70 in the 32 kDa subunit in the M80PS ribbon model. Domains are
colored according to the previous scheme (Figure 2). Glu 70 is not modified in the pRPA
state but is modified in the ssDNA:pRPA state. Glu 70 is in close proximity to the winged
helix on the C terminus of the 32 kDa subunit. The change in modification suggests that
the winged helix lies closer to the core of the 32 kDa subunit in the phosphorylated
state, but moves away when it is bound to DNA.
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Figure 31. View of Lys 88 in the putative binding site of DBD F in the 70 kDa subunit in
the M80PS ribbon model. Domains are colored according to the previous scheme (Figure
2). Lys 88 is modified in the ssDNA:RPA bound state and is not modified in the
ssDNA:pRPA bound state. Lys 88 is in close proximity to N terminus of the 32 kDa
subunit, which is a known site for phosphorylation.
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Figure 32. View of Asp 306 & Lys 379 in DBD B of the 70 kDa subunit in the M80PS
ribbon model. Domains are colored according to the previous scheme (Figure 2). Asp
306 and Lys 379 are modified in the ssDNA:pRPA state but are not modified in the
ssDNA:RPA state.
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Figure 33. View of Asp 307 & Lys 410 in DBD B of the 70 kDa subunit in the M80PS
ribbon model. Domains are acolored according to the previous scheme (Figure 2). Both
Asp 307 and Lys 410 are modified in native RPA and ssDNA:RPA, but are not modified in
pRPA or ssDNA:pRPA, suggesting that this portion of DBD B becomes less exposed when
phosphorylated.
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modified in ssDNA:pRPA (Figures 28 & 29). In the 32 kDa subunit, again 1 amino acid,
glutamate 70, was not modified in pRPA and was modified in ssDNA:pRPA (Figure 30). In
the 70 kDa subunit, 2 amino acids showed differences in modification. Lysine 88 was
modified in pRPA and was not modified in ssDNA:pRPA (Figure 31). Aspartate 306 was
not modified in pRPA and was modified in ssDNA:pRPA (Figure 32).
RPA vs pRPA
When comparing RPA with pRPA (Table 10), there was no difference in the 8
surface accessibly modified amino acids within the 14 kDa subunit (Table 10). Of the 12
amino acid targets in the 32 kDa subunit, glutamate 70 was modified in RPA, but was
not modified in pRPA (Figure 30). In the 70 kDa subunit, 2 amino acids, aspartate 307
and lysine 410, were modified in RPA, but were not modified in pRPA (Figure 33).
ssDNA:RPA vs ssDNA:pRPA
Lastly, native RPA covalently crosslinked to ssDNA was compared to pRPA
covalently crosslinked to ssDNA (Table 11). Aspartate 103, in the 32 kDa subunit was not
modified in ssDNA:RPA, but was modified in ssDNA:pRPA (Figure 34). In the 70 kDa
subunit, 6 amino acids reacted differently in the native and phosphorylated forms.
Lysine 263 was not modified in ssDNA:RPA and was modified in ssDNA:pRPA (Figure 35),
and lysine 410 was modified in ssDNA:RPA and not modified in ssDNA:pRPA (Figure 33).
Lysine 273 (Figure 35), aspartate 307 (Figure 32), and lysine 379 (Figure 32) were

150

Figure 34. View of Asp 103 in the putative binding site of the 32 kDa subunit in the
M80PS ribbon model. Domains are colored according to the previous scheme (Figure 2).
Asp 103 is not modified in the ssDNA:RPA state but is modified in the ssDNA:pRPA state.
As this residue lies in the putative binding site of DBD D, it suggests that all or a portion
of the binding site is unoccupied by ssDNA in the phosphorylated state.
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Figure 35. View of Lys 263 in the putative binding site of DBD A and Lys 273 in the linker
region between DBD A and DBD B of 70 kDa subunit in the M80PS ribbon model.
Domains are colored according to the previous scheme (Figure 2). Both Lys 263 and Lys
273 are exposed in native RPA and pRPA, but are blocked by ssDNA in the bound states.
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modified in ssDNA:pRPA and were not modified in ssDNA:RPA. Finally, lysine 88 (Figure
31) was not modified in ssDNA:pRPA, but was modified in ssDNA:RPA.
Discussion
RPA vs ssDNA:RPA
The 14 kDa subunit had 2 amino acids, aspartate 22 and lysine 49, which were
modified in the RPA but were not modified in ssDNA:RPA. These amino acids lie in a
groove on DBD E. This feature is common to OB fold domains9 and is very frequently an
oligonucleotide/polysaccharide binding region. When in its native state, aspartate 22
and lysine 49 are surface accessible and thus available for modification. When the 14
kDa subunit binds to ssDNA, aspartate 22 and lysine 49 become blocked by the ssDNA
adduct and are inaccessible to the chemical modifying reagents (Figures 28 & 29).
The 32 kDa subunit had 1 amino acid with different reactivity between RPA and
ssDNA:RPA, aspartate 103. Aspartate 103 is modified in RPA, but is not modified in
ssDNA:RPA. Aspartate 103 is in the OB fold of DBD D and is occluded by the bound
ssDNA adduct (Figure 34).
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In the 70 kDa subunit, lysine 263 lies within the putative binding site of DBD
A and lysine 273 is interposed between DBD A and B. Both residues are blocked by
the ssDNA adduct running from DBD A to DBD B (Figure 35). Both are modified when
in RPA but are not modified in the ssDNA:RPA suggesting that they are blocked by a
ssDNA adduct. Aspartate 307 and lysine 379 are in DBD B, but lie outside the binding
groove of the DBD. Both are modified in the RPA and are not modified in the
ssDNA:RPA. Lysine 379, like lysine 273, lies between DBD A and DBD B and is blocked by
the ssDNA strand running from DBD A to DBD B (Figure 32). Aspartate 307, however is
outside the direct pathway of the ssDNA and would require a local variation in
conformation to block the accessibility of this residue from covalent chemical
modification (Figure 32). Lysine 88 is within DBD F of the 70 kDa subunit and represents
a conformational change to go from exposed and accessible within RPA to buried and
unreactive within ssDNA:RPA (Figure 31).
pRPA vs ssDNA:pRPA
Aspartate 22 and lysine 49, in the 14 kDa subunit were modified in the pRPA, and
appear to be similarly blocked by a DNA adduct in ssDNA:pRPA (Figures 28 & 29).
Glutamate 70 in the 32 kDa subunit was not modified in the pRPA and was
modified in ssDNA:pRPA. This suggests that the 32 kDa subunit is more compact in the
pRPA but opens as it becomes bound to ssDNA (Figure 30).
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Lysine 88, in the 70 kDa subunit was modified in pRPA and not modified in the
ssDNA:pRPA. Again, this suggests a local conformational change that provides
accessibility to the modified amino acid within pRPA but limits accessibility within
ssDNA:pRPA (Figure 31). Aspartate 307 was not modified in pRPA and was modified in
ssDNA:pRPA (Figure 32). This data again represents local changes to the conformation
as the accessibility of each amino acid target changes allowing the reaction to occur in
the modified state.
Native RPA vs pRPA
Overall, there was significant agreement of the reactivities of probed amino
acids between all subunits of RPA and pRPA, with only minor changes between 32 and
70 kDa subunits. In the 32 kDa subunit, glutamate 70 was modified in RPA, but was not
modified in pRPA (Figure 30). This suggests a difference in accessibility of glutamate 70,
with it being accessible and thus modified in RPA, but being inaccessible in the
phosphorylated state.
For the 70 kDa subunit, there were 2 amino acids, aspartate 307 and lysine 410,
that were modified in RPA, but were not modified in pRPA (Figure 33). Both amino acids
are within DBD B and are 12.6 Angstroms apart, and again, this suggests local
rearrangement, blocking accessibility of the chemical modifying reagents in the
phosphorylated state.
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ssDNA:RPA vs ssDNA:pRPA
Aspartate 103, in the 32 kDa subunit was not modified in ssDNA:RPA, but was
modified in ssDNA:pRPA (Figure 34). Aspartate 103 is part of the β barrel of DBD D and
extends outward from the protein in the M80PS model. This residue is most likely
blocked by the N terminus of the 32 kDa subunit in ssDNA:RPA. Consistent with
increased reactivity in the phosphorylated adduct, the N terminus of the 32 kDa subunit
straightens and extends outward and would allow modification in the phosphorylated
state48.
In the 70 kDa subunit, there were 6 amino acids with different reactivities
between ssDNA:RPA and ssDNA:pRPA, (D 307, K 88, K 263, K 273, K 379, & K 410). Lysine
88 and lysine 263 were not modified in ssDNA:RPA but were modified in ssDNA:pRPA.
Aspartate 307, lysine 273, lysine, 379, and lysine 410 were modified in ssDNA:RPA and
were not modified in ssDNA:pRPA. All of these residues, with the exception of K 88, are
in DBDs A & B. It suggests that local conformational changes occur in the high affinity
binding sites of DBDs A & B which alter the conformation of the binding pocket between
ssDNA:RPA and ssDNA:pRPA. As DBDs A & B not only bind ssDNA, but have also been
shown to have interaction with some of RPA’s protein binding partners, the change
between native and phosphorylated states again suggests that this rearrangement could
influence which of those proteins make a good binding partner for each of the 2 RPA
states. It should be noted that phosphorylation may change electrostatic interactions for
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all amino within the phosphylated species and thus affect the ability of each amino acid
to be modified.
Kinetic Evaluation for MRAN analyses of Replication Protein A
To refine the data collected from the chemical modification reactivity analyses,
reaction kinetics for each amino acid were evaluated. This provided greater resolution
to the gross assessment of the chemical modification reactivities of the amino acids
queried in this study (Tables 4 & 7). This data was primarily used to examine the
placement of DBDs A & B on the trimerization core. The data suggests that DBDs A & B
are docked on the trimerization core of native RPA, as shown in the M80PS model.
Aspartate 45 and lysine 104 in the 14 kDa subunit are both part of DBD E and lie
proximal to DBD B of the 70 kDa subunit. Both residues were scored unreactive and
therefore not exposed in the native RPA state, suggesting that the positioning of DBD B
on the trimerization core in the M80PS model is accurate. Additionally, lysine 183, which
is on DBD A of the 70 kDa subunit and lies in proximity to DBD E of the 14 kDa subunit,
was also scored unreactive and supports the placement of DBD A on the trimerization
core. However, when RPA is bound to ssDNA, aspartate 45 and lysine 104 of the 14 kDa
subunit, as well as, lysine 183 of DBD A are scored reactive. This suggests that DBDs A &
B detach from the trimerization core or at least undergo substantial changes in their
docking location when bound to ssDNA. The reactive scores for aspartate 22 and lysine
49 of the 14 kDa subunit support this contention. Both D 22 and K 49 lie within the
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putative binding site of DBD E and were scored reactive in the native state, but become
unreactive and presumably inaccessible when the 14 kDa subunit of RPA is bound to
ssDNA (Figures 28 & 29). Also, photo crosslinking data between ssDNA and RPA show
the reaction between DBD E and ssDNA (Table 3). For this to occur, DBDs A & B must
detach or move from DBD E to allow the access of ssDNA to the OB fold of DBD E.
The orientation and placement of DBDs A & B when RPA is phosphorylated or
phosphorylated and bound to ssDNA was also of interest. It has been suggested that
RPA undergoes a structural change when it is phosphorylated. However, the extent of
change, and how that change mimics or differs from unphosphorylated RPA is not
understood. Reaction data for all amino acids that lie within subunit interfaces between
DBDs A & B and the RPA trimerization core were the same as compared to their
unphosphorylated RPA counterparts. This implies that DBDs A & B are similarly docked
to the trimerization core of RPA when the molecule is phosphorylated and detach from
the trimerization core when phosphorylated and bound to ssDNA.
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Table 12. Scoring rubric for kinetic evaluation of chemical reactivities of amino acids.
Each mass spectrum peak corresponding to an observed peptide was evaluated by this
rubric dependent upon the indicated number of modifications (table on following 2
pages).
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Sites are classified as
U: Unreactive (no shift)
R: reactive (shifted and unshifted (parent) peptides
present)
V: very reactive (all peptides are shifted)
number of modification the peptide is shifted by:
0

1

one site per peptide
U
R
V
two sites per peptide
U2
UR
UV
R2
RV
V2
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2

3

4

Three sites per
peptide
U3
U2R
U2V
R2U
VRU
V2U
R3
R2V
V2R
V3
Four Sites per
peptide
U4
U3R
U3V
R2U2
VRU2
V2U2
R3U
R2VU
V2RU
V3U
R4
R3V
V2R2
V3R
V4
0

1

2
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3

4

Another area of interest within RPA is DBD F on the N terminus of the 70 kDa
subunit. The kinetic scoring data was used to evaluate whether there was a change in
reactivitiy of residues in the interfaces between DBD F and DBD D of the 32 and DBD E
of the 14 kDa subunits, respectively. For all amino acids scored within interacting sites,
there was no change in reactivities between native and phosphorylated, native and
ssDNA bound, phosphorylated and phosphorylated ssDNA bound, or native ssDNA
bound and phosphorylated ssDNA bound states. This suggests that DBD F does not
reorient under any of the binding states examined. Data from the covalent photo
crosslinking of RPA and pRPA indicates that DBD F is bound to ssDNA in the native state,
but not in the phosphorylated state. MRAN data suggests that this region does not
undergo local conformational change with phosphorylation for the amino acids studied
here, or perhaps that DBD F presents a different electrostatic environment when
phosphorylated that is not conducive to crosslinking of ssDNA, though it is crosslinked in
the unphosphorylated state.
Evaluation of Modification Reactivity with proposed structures
The chemical modification reactivity analysis data was then used to evaluate
structures of pieces of RPA and the structure proposed by the Alter laboratory (1JMC,
1L1O, 1FGU, 1DPU, 3KDF, 1EWI, 4R4C, M80PS, and 4GNX) to determine their relevance
to solution state RPA whose structure has been probed in this thesis dissertation (Tables
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5 & 6). As previously noted, the structures evaluated were proposed based on x-ray
crystallographic, NMR, and simulated annealing data for the protein.
For the 14 kDa subunit, crystallographically derived models 3KDF and 1L1O were
consistent the in vitro data reported here for all chemically modified amino acids in this
study (Tables 5 & 6). The M80PS model proposed by our lab for the apo structure of RPA
did not match the chemical modification results reported here for the EDC glycine
methyl ester or sulfo-NHS acetate reactions well, with only aspartate 3 in the EDC
reaction and lysine 33 in the sulfo-NHS acetate reaction having surface exposures that
corresponded to experimental results (Tables 5 & 6). As M80PS is a model built by
additively placing crystal structures reported for pieces of RPA8 onto the reported
crystal structure of the trimerization core of RPA, the solvent accessible surface areas of
amino acids within subunit-subunit and domain-domain interfaces, as well as flexible
linker regions for each piece were often one of several simulated annealing structures,
that appeared to correspond best with experimental data. The majority of the
discrepancies between the M80PS model and the data reported here are for surface
exposures for amino acids that are in regions between unstructured sequence and
domain interfaces. These unstructured sequences in M80PS are 1 of 15 interconvertible
conformations reported for the inherently unstructured regions and likely differ from
the structure in solution and would account for the differences between the M80PS
structure and the experimental results reported here.
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For the 32 kDa subunit, M80PS, and the crystallographically derived 1L1O and
1DPU structures, all are consistent with the experimental results for the EDC reaction of
RPA and pRPA as well, with the exception of glutamate 70 which is buried within the
M80PS model but is reactive within the experimental results (Table 5). Glu 70 faces the
winged-helix on the C terminus of the 32 kDa subunit. It is believed that the wingedhelix is loosely tethered to DBD D. Its positioning on DBD D, in the M80PS model, is
again 1 of several possible interaction sites. Results from the sulfo-NHS acetate reaction
for the 1L1O and 1DPU reported structures matched experimental results (Table 6).
M80PS did not match results for lysine 85 and was inconclusive for lysine 171 (Table 6).
Lysine 85 is also blocked by a loose tether in the M80PS model, and its placement can
vary.
For the 70 kDa subunit, the crystallographically derived 1FGU and 1JMC
structures matched all experimental results for the EDC reactions for both RPA and
pRPA (Table 5). M80PS matched RPA and pRPA well, by coinciding with 11 of the 13
amino acids probed (Table 5). The sulfo-NHS reactions of RPA and pRPA, 1FGU and 1JMC
again matched all experimental results (Table 6). M80PS was consistent with
experimental results matching 13 of the 15 probed amino acids (Table 6). The exception
to these results again resides in the ssDNA:RPA and ssDNA:pRPA models. As previously
indicated, the data suggests that DBDS A & B detach from the trimerization core and
function independently from the core molecule. M80PS accurately reflects the structure
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when the protein is DNA free. However, it does not accurately represent the ssDNA
bound structure. The crystallographically derived structure, 4GNX, proposed by
Pavletich et al. is consistent with the data reported here for the placement of DBDs A &
B when RPA is bound to ssDNA.
While the complete RPA heterotrimer has not been examined by x-ray
crystallography and NMR, many truncated species have been studied. By comparing the
predicted surface accessibility of specific amino acids within each model with direct in
vitro experimentation, the validity of each structure was evaluated. Our data supports
the reported structures for the models previously mentioned, with the exception of
minor changes for native and phosphorylated RPA free of ssDNA substrate. This
suggests that not only do these models correctly represent the portions of the protein
that they directly studied, but taken as a whole, a picture of the complete RPA
heterotrimer in native and phosphorylated states can be derived. The data that suggests
DBDs A & B detaches from the trimerization core and calls into question the validity of
these structures for the molecule when bound to ssDNA substrate. It suggests that a
reevaluation of the structures are necessary when describing the molecule as it interacts
with ssDNA.
As a means of understanding the reported structures for RPA, the structural and
functional interactions described in the literature were compared to our reported
experimental results. In comparing NMR data by Brosey et al.19 from a 2009 paper,
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there were several discrepancies between the reported and postulated structural
interactions of RPA and ssDNA with our experimental data. Brosey et al. cited no
reactivity of the C terminal region of the 32 kDa subunit with a ssDNA 30mer. Our
experimental data from the covalent photo crosslinking of RPA and pRPA directly
contradicts this argument. The C terminus extends from methionine 200 through the
terminal glutamate 270. We report multiple peptides covalently crosslinked with ssDNA
in this portion of the protein. Peptides bound were as follows: (RPA 218-231, 232-243, &
257-270 and pRPA peptides 235-248, & 257-270, data not shown). This suggests that the
C terminus of the 32 kDa subunit is juxtaposed away from the trimerization core when
bound to ssDNA and is available for photo crosslinking to RPA bound ssDNA. Further,
Brosey et al. showed no interaction of the N terminus of the 70 kDa subunit (residues 1114) with ssDNA. Again, our experimental data directly contradicts this result. In RPA
peptides 88-96 & 103-122 (data not shown) are directly covalently crosslinked with
ssDNA. Brosey et al. additionally suggested that RPA 70 DBDs A & B are associated with
the trimerization core when bound to ssDNA. Again, our experimental data contradicts
this result. The direct covalent crosslinking of DBD E of the 14 kDa subunit as well as the
reactivity data for aspartate 45 and lysine 104 in the 14 kDa subunit and lysine 183 in
DBD A can only result when DBDs A & B are separated from the trimerization core and
allow access or the ssDNA with this region.
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In a 2012 paper Pavletich et al.71 used x-ray crystallography to examine a
truncated structure of RPA from U. maydis, (4GNX). The N terminus of the 70 kDa
subunit and the C terminus of the 32 kDa subunit were not present. The justification for
the truncated species is lack of direct experimental evidence for interaction with ssDNA.
They further present data that the linker region between DBDs B & C is buried when the
protein is bound to ssDNA. Our data for RPA and pRPA contradicts and coincides with
differing portions of this structure. In RPA, peptides corresponding to N terminus of the
70 kDa subunit and the C terminus of the 32 kDa subunit as well as the B-C linker region
of the 70 kDa subunit were covalently chemically modified and covalently photo
crosslinked with ssDNA. The unstructured region between DBD B and DBD C, peptides
415-422 & 413-431 (data no shown) in RPA and 413-431 & 416-422 (data not shown) in
pRPA, were covalently modified by the EDC glycine methyl ester reaction. The
modification of the peptides within this region can only occur if the portion of the
protein between DBD B and DBD C is solvent accessible. In addition to the truncations
mentioned in the previous paragraph, (the N terminus of the 70 kDa subunit and the C
terminus of the 32 kDa subunit), were also targets for direct covalent ssDNA binding.
This calls into question the justification of the truncated species used for this study.
However, 4GNX does present DBDs A & B as disjoined from the trimerization core when
bound to ssDNA. The loose tether to the trimerization core presented in 4GNX agrees
with our experimental results and allows for binding of the 14 kDa subunit with ssDNA.
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It should be noted that the reported structure by Pavletich et al. 71 is for the protein in
crystal state and may not accurately describe the structure of the protein in a solution
state. It is the inherent difference between crystal and solution states that could
account for the discrepancies between the data presented by Pavletich et al. and the
data reported here.
A 2015 paper, by Brosey et al.38 measured the rotational independence or
interdependence of DBD A and DBD B in the absence of ssDNA or in the presence of a
ssDNA 10mer. This paper cited great independence between the unbound DBDs, but
noted an interdependent rotation when bound to ssDNA. The latter agrees with all
reported structures of DBDs A & B bound to ssDNA. Brosey et al. also measured the
rotational independence of DBD F to the rotationally dependent DBDs A & B in the
presence of the ssDNA ligand. They noted completely independent mobility between
domains A & B to domain F in the presence of ssDNA substrate. Here, they again used a
ssDNA 10mer as a substrate. Our experimental results, with a ssDNA 30mer, show direct
covalent photo crosslinking between DBD F and ssDNA. We argue that the ssDNA 10mer
is not large enough to bind A & B and extend to F. It is the insufficient length of this
substrate that allows for the free rotation of the N terminus.
A 2005 paper by Shell et al.79 reported the protection of lysines in the DNA
binding sites of DBDs A, B, C, and D from sulfo-NHS-biotin modification. Shell et al.
reported protection of lysines 183, 259, 263, 343, 489, 577, and 588 in the 70 kDa
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subunit. Our data agrees with all but 2 of these residues. We did not see protection of
lysines 183 and 259 in DBD A. We postulate that it is the difference in the physical
properties of their reagent in relation to ours that did not allow the modification of
these residues. Sulfo-NHS biotin places a large (MW 244.31 of 13.1 Angstrom length)
biotin on the primary amine in a lysine. This reagent, due to its size, could make it a poor
reagent for reaction with these residues. The acetyl group placed on the primary amine
in lysines in the sulfo-NHS acetate reaction is significantly smaller (MW 43.05) and
subsequently more accessible to smaller ligand binding sites. Further, Shell et al. did not
see protection of any lysines in DBD D of the 32 kDa subunit nor DBD E of the 14 kDa
subunit. We report protection of lysine 49 (Figure 28) in the 14 kDa subunit when it is
bound to ssDNA. Further, because we employed a second modifying reagent, we also
report protection of aspartates 22 (Figure 29) and 95 (Figure 36) in the 14 kDa subunit,
as well as aspartates 95, 96, and 103 (Figure 37) in the 32 kDa subunit, consistent with
our placement of the ssDNA 30mer in the RPA structure.
The compilation of multiple reported and postulated structures when compared
to direct experimental evidence demonstrates that the structure of Replication Protein
A is still not completely understood. As various laboratories report truncated structure,
and postulate the whole structure of the protein, here we present data for the complete
protein in solution that provides a more insightful approach to structure determination.
When this data is taken in conjunction with the previously reported and postulated
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Figure 36. View of Asp 95 in the 14 kDa subunit in the M80PS ribbon model. The model
is colored according to the previous scheme (Figure 2). Asp 95 is blocked by a ssDNA
adduct in the ssDNA bound state, but is modified in the ssDNA free state.
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Figure 37. View of Asp 95, 96, and 103 in the 32 kDa subunit in the M80PS ribbon model.
The model is colored according to the previous scheme (Figure 2). Asp 95, 96 and 103
are blocked by a ssDNA adduct in the bound state, but are modified in the ssDNA free
state.
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structures, a higher resolution understanding of RPA in native, phosphorylated, ssDNA
bound, and phosphorylated ssDNA bound states is achieved. It is through this analysis
that a full model of RPA in its various reaction states can be determined. The
rearrangement and adjustment of models to correspond with experimental data
obtained from MRAN, will give a more precise depiction of the complete RPA molecule.

Through the use of covalent photo crosslinking, in conjunction with mass
spectral analysis, we have mapped the sites of covalent chemical bonds between
specific amino acids and poly dT30 in all 3 subunits of RPA in both its native and
phosphorylated states. We have demonstrated that the 14 kDa subunit has direct
interaction with ssDNA in both native and phosphorylated states. Further, we have
demonstrated that minor structural changes occur between native and phosphorylated
species in all 3 subunits and provide different target amino acids that are able to
covalently bind with ssDNA under different experimental conditions. Further, we have
detected changes at the local level in all DBDs and subunits between, native,
phosphorylated, ssDNA bound, and phosphorylated ssDNA bound states. We have
demonstrated that the changes in phosphorylation state do not affect global structure
of the molecule, but does alter the ssDNA binding interactions between native and
phosphorylated species. We have noted that DBDs A & B must detach from the
trimerization core to correspond with ssDNA covalent binding and chemical
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modification reactivity data for native and phosphorylated RPA. This is a global change
for the orientation of DBDs A & B, when the protein is bound to ssDNA. This suggests
that RPA is a highly flexible and dynamic molecule that undergoes significant
rearrangement between apo and bound states. More so, the data reported here
supports the structure (M80PS) proposed by our lab8 for RPA in its unphosphorylated
and ssDNA free state.
Probing the structure of RPA with chemical modifying reagents that target
different amino acids than those used in this study will further refine the physical
understanding of the molecule. Investigation into the local changes, and more
specifically, how these changes affect protein-protein interactions and protein-DNA
interactions will broaden the understanding of the role of the individual subunits and
DBDs of RPA. RPA is a complex and modular protein, but with continued study and
analysis, the full scope of the conformations it adopts to achieve differing functions
within the cell will be more fully understood.
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Structural Basis for RPA’s Biological Functions
The roles of RPA within the cell have proven to be both many and essential. RPA
is the highest affinity single strand DNA binding protein within the cell58, but also serves
the role of a key player involved in DNA maintenance and metabolism49,80,81. To achieve
this, RPA not only binds ssDNA45, dsDNA82, and RNA83, but interacts with proteins that
cover the scope of cellular functionality49. RPA, in conjunction with its protein binding
partners, helps to regulate replication, recombination, damage repair, as well as cell
cycle and DNA check point signaling45,47,50,84. Our and other’s experimental results show
that RPA is a dynamic protein and highly modular. RPA adapts its conformation in
response to its DNA binding and phosphorylation interactions state 71. It is its inherent
modularity that allows RPA to function distinctly depending upon which task it is
involved in.
Cell Cycle
The modular nature, as well as the differing conformations that RPA adopts
under each reactive state brings forth intriguing questions as to what role RPA serves
throughout the cell cycle. Immunolocalization of RPA shows it in the nucleus in
replication foci prior to replication through S phase49. More so, punctate stains of RPA
show its persistence in the nucleus through all cell cycles53. RPA is phosphorylated at the
onset of S phase and remains phosphorylated through early mitosis47, but becomes
dephosphorylated in the latter stages of mitosis49. One primary function is for RPA to
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bind to ssDNA at the replication fork85. In taking into account our reported data that
DBDs A & B, dissociate from the trimerization core upon ssDNA binding (Ch3. In this
dissetation), this suggests that the many of the protein binding partners of RPA that
bind to multiple subunits/domains of RPA simultaneously would not make favorable
substrates for binding to this extended state during replication. This conjecture is
supported by the fact that many of these binding partners are essential components in
the DNA damage repair pathways. Adopting a conformation that dissuades binding of
these proteins, would aid replication by lowering affinity of protein binding partners
involved in other processes in the cell. As RPA is phosphorylated during S phase, this too
changes local conformation of the protein in DNA binding sites, as well as in sites of
subunit and domain interaction (Ch. 4 in this dissertation). Local rearrangement of the
protein at the sites of DNA binding or within inter subunit and inter domain regions
would allow function specific interaction within the replication foci and would aid
recruitment of proteins involved in DNA metabolism. It has further been hypothesized
that phosphorylation of RPA functions in cellular signaling. The rearrangement of DBDs
as well as the sites of inter subunit and inter domain interaction would support this
hypothesis by changing affinity of DBDs to ssDNA as well as change affinity for specific
protein binding ligands under each reactive state. When RPA detaches from the
replication foci, it returns to its compact, dephosphorylated state. Returning to this
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conformation would essentially reset RPA as a substrate and allow it to bind to damaged
DNA or protein partners that function in other pathways within the cell.
MRAN data for the N terminus of the 70 kDa subunit, a site for protein-protein
interaction, suggests that the domain functions independently of DNA binding or
phosphorylation state under the conditions tried here (Ch. 4 in this thesis). It would
remain a susceptible site for protein-protein reactions with little influence in its
reactivity based on the conformational changes reported here.
DNA Damage
As noted earlier, RPA is hyperphosphorylated during DNA damage67. Specifically,
the N terminus of the 32 kDa subunit as well as portions of the 70 kDa subunit are
phosphorylated53,48. However, phosphorylation has not been shown to be essential for
RPA’s functions in nucleotide excision repair and base excision repair84,6. Again, it seems
that the conformation of RPA between the DNA free-state and bound-state influences
its function during DNA damage. When in a DNA free-state, both RPA and pRPA are in a
compact conformation with all DBDs from the 70, 32, and 14 kDa subunits associated
around the trimerization core of the protein. The proximity of DBDs A & B to DBDs C, D,
and E allow for interactions with protein binding partners that span multiple subunits.
The nucleotide excision repair protein Xeroderma pigmentosum A (XPA) interacts with
both the 70 and 32 kDa subunits of RPA simutaneously44. The close association of the 3
subunits of RPA, when in the DNA free-state, present favorable binding sites for this
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interaction. As RPA binds to ssDNA at a site of DNA damage, the XPA ligand interaction
would change. It would seem likely that XPA would detach from RPA when it is in an
extended state with DBDs A & B detached from the 32 kDa subunit. By freeing RPA from
the XPA ligand, RPA would then be able to recruit other known protein interacting
partners like, Xeroderma pigmentosum F, (XPF)86, and ERCCI87, that are also involved in
nucleotide excision repair. Additionally, both RAD 52 (which is essential for homologous
recombination)68 and uracil DNA glycosylase (which is essential for base excision
repair)88 have been shown to bind to the same interacting site as XPA on the 32 kDa
subunit. Making XPA a less favorable substrate, would decrease competition for these
proteins and allow RPA to assume a different function within the cell.
Another example of how this modularity influences function, is the interaction of RPA
with DNA protein kinase (DNA-PK). DNA-PK aids phosphorylation of RPA6 ,forms a
complex with the 70 kDa subunit6 and is able to identify and bind to sites of DNA
damage as well as inhibit DNA polymerase alpha primase activity56. DBDs A & B of the
70 kDa subunit interact with DNA polymerase alpha primase in the absence of
phosphorylation and DNA damage73. Phosphorylation of RPA by DNA protein kinase,
does not significantly change the structure of the 70 kDa subunit but does make local
changes that influence the amino acids that bind ssDNA within DBDs A & B (Ch. 4 in this
thesis). As it is believed that this is also the site of DNA polymerase alpha primase
binding, local changes to structure in the binding sites of DBDs A & B would influence its
181

interaction with DNA polymerase alpha primase. This could slow or hinder replication
and allow repair machinery to function.
Nontraditional Function
Another aspect of RPA is its ability to bind to non b-form DNA. More specifically,
RPA has been shown to bind to triplex and quadraplex DNA89,90. The local
conformational rearrangement of DBDs and inter domain and inter subunit reaction
sites could potentially aid this function. The ability of the 14 kDa subunit of RPA to bind
DNA independently of DBDs A, B, C, and D (Ch. 3 in this thesis), suggest that RPA has the
ability to bind to DNA in an alternative mode that does not follow its previously
reported action. It is possible that the interaction of the 14 kDa subunit is required for
binding the nontraditional DNA substrates.
Closing Remarks
The primary function of RPA, binding ssDNA, has the most drastic effect on the
structure of the protein and subsequently dictates its functions and interactions within
the cell. The change from the compact ssDNA free molecule to an extended ssDNA
bound protein not only influences the global structure of RPA, but changes the proteins
ligand binding sites and inherently its function within the cell. Phosphorylation of the
protein serves not only as a cellular signal, but allows slight adjustments to protein and
DNA interacting sites that in turn influence its affinity for specific ligands. It is the
adaptive plasticity of the protein that allows it to be involved in so many cellular
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processes, and it is this modularity that continues to provide newly discovered and
vitally important functions within the cell.
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